Fission and proliferation of peroxisomes  by Schrader, M. et al.
Biochimica et Biophysica Acta 1822 (2012) 1343–1357
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isReview
Fission and proliferation of peroxisomes☆
M. Schrader ⁎, N.A. Bonekamp, M. Islinger
Centre for Cell Biology & Dept. of Biology, University of Aveiro, 3810–193 Aveiro, PortugalAbbreviations: ER, endoplasmic reticulum; Pex, pero
liferator activated receptor γ coactivator-1α; PMP, pe
PPAR, peroxisome proliferator activated receptor; PPR
sponse element; ROS, reactive oxygen species
☆ This article is part of a Special Issue entitled: Metabo
Peroxisomes in Health and Disease.
⁎ Corresponding author at: Centre for Cell Biology &
Aveiro, Campus Universitário Santiago, 3810–193 Ave
370 200x22789; fax: +351 234 372 587.
E-mail address: mschrader@ua.pt (M. Schrader).
0925-4439/$ – see front matter © 2012 Elsevier B.V. All
doi:10.1016/j.bbadis.2011.12.014a b s t r a c ta r t i c l e i n f oArticle history:
Received 31 October 2011
Received in revised form 22 December 2011
Accepted 23 December 2011
Available online 31 December 2011
Keywords:
Peroxisome proliferation
Organelle dynamics
DLP1/DRP1
FIS1
Mff
Pex11Peroxisomes are remarkably dynamic, multifunctional organelles, which react to physiological changes in
their cellular environment and adopt their morphology, number, enzyme content and metabolic functions
accordingly. At the organelle level, the key molecular machinery controlling peroxisomal membrane elonga-
tion and remodeling as well as membrane ﬁssion is becoming increasingly established and deﬁned. Key
players in peroxisome division are conserved in animals, plants and fungi, and key ﬁssion components are
shared with mitochondria. However, the physiological stimuli and corresponding signal transduction path-
ways regulating and modulating peroxisome maintenance and proliferation are, despite a few exceptions,
largely unexplored. There is emerging evidence that peroxisomal dynamics and proper regulation of perox-
isome number and morphology are crucial for the physiology of the cell, as well as for the pathology of the
organism. Here, we discuss several key aspects of peroxisomal ﬁssion and proliferation and highlight their
association with certain diseases. We address signaling and transcriptional events resulting in peroxisome
proliferation, and focus on novel ﬁndings concerning the key division components and their interplay.
Finally, we present an updated model of peroxisomal growth and division. This article is part of a Special
Issue entitled: Metabolic Functions and Biogenesis of Peroxisomes in Health and Disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Peroxisomes are dynamic, multifunctional organelles that contrib-
ute to numerous anabolic and catabolic pathways and are thus essen-
tial for human health and development. Common functions include
the metabolism of hydrogen peroxide and the oxidation of fatty
acids. However, several specialized functions have been acquired
such as plasmalogen biosynthesis in mammals, photorespiration
and glyoxylate cycle in plants, penicillin biosynthesis in fungi, and
glycolysis in trypanosomes. In animals, peroxisomes are as well
involved in the synthesis of bile acids, mediators of inﬂammation
(e.g. leukotrienes) and docosahexaenoic acid, a modulator of neuro-
nal function [1]. A new biological function for peroxisomes in anti-
viral innate immunity and anti-viral (MAVS) signaling was recently
discovered [2]. To adapt to the changing physiological requirements
of a cell or organism, peroxisomes have to constantly adjust their
morphology, number, enzyme content and metabolic functionsxin; PGC-1α, peroxisome pro-
roxisomal membrane protein;
E, peroxisome proliferator re-
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rights reserved.accordingly. This requires dynamic processes which modulate perox-
isome abundance, e.g. by peroxisome formation (biogenesis), degra-
dation (pexophagy), or inheritance (cell division or budding) [3,4].
Peroxisomes can form by growth and division (ﬁssion) from pre-
existing ones [5,6]. Alternatively, they can also arise from the ER
[7–9]. This de novo formation was ﬁrst discovered in mutant cells
completely lacking peroxisomes after reintroduction of the deﬁcient
gene (PEX19, PEX3, or PEX16, which are thought to mediate peroxi-
some membrane biogenesis) (see Chapter 2, this issue). Recent pub-
lications indicate, that this process may also occur under normal
conditions [10,11] involving the formation of vesicles containing a
subset of peroxisomal membrane proteins (PMPs) budding from
specialized ER sites [12,13]. Currently, however, the proportional con-
tribution of both biogenesis pathways to the maintenance and abun-
dance of peroxisomes is largely unknown and may vary considerably
among different organisms. Here, we will focus mainly on peroxi-
some formation by growth and division and highlight recent ad-
vancements in the ﬁeld. It is evident now, that an imbalance in
peroxisome abundance, e.g. by impairment of regulatory pathways
or defects in key division components can contribute to disorders dis-
playing phenotypes, which often differ from those of classical perox-
isome biogenesis disorders (see Chapter 3, this issue).
The terms “peroxisome proliferation” or “peroxisome multiplica-
tion” are commonly used to deﬁne the mode of peroxisome gen-
eration. Whereas “multiplication” refers to the maintenance of
peroxisome numbers, peroxisome proliferation generally describes a
pronounced increase in peroxisome number (usually after external
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ation” will be used interchangeably, as both processes likely require
the same machinery at the organelle level. Peroxisome proliferation
has to be controlled by coordinated signaling events in the nucleus
thus enhancing transcription of proliferation-relevant genes and con-
certed actions of biogenesis proteins at the cellular sites of peroxi-
some formation. Despite a few exceptions, the extracellular and
intracellular signaling cascades involved in peroxisome proliferation
are largely unknown. Key players in peroxisome division have, how-
ever, been identiﬁed during the last years and found to be conserved
in animals, plants and fungi. Division of peroxisomes is preceded by
elongation of the organelle membrane involving the conserved mem-
brane protein Pex11p. Final ﬁssion requires dynamin-like proteins
with GTPase activity and associated receptor and adaptor proteins
(e.g. DLP1/Drp1 and its receptors Fis1 and Mff in mammals). Notably,
these key components are shared with mitochondria which is a com-
mon strategy used by mammals, fungi and plants. Peroxisome forma-
tion from either the ER or by growth and division appears to follow a
maturation process involving the recruitment of new membrane and
matrix proteins.
In summary, peroxisome abundance is controlled at various stages
and sites. On the one hand, it is regulated by controlled transcription
of biogenesis- and division-related genes. On the other hand, peroxi-
some division requires a timely and spatially coordinated series of in-
teractions between the various components involved. In the
following, we will provide a comprehensive overview of our current
knowledge on ﬁssion and proliferation of peroxisomes. We will ﬁrst
address signaling and transcriptional events resulting in peroxisome
proliferation, and will afterwards focus on novel ﬁndings concerning
the key components of the peroxisomal ﬁssion machinery and their
interplay. The most recent ﬁndings have been incorporated in an
updated model of peroxisomal growth and division.
2. Regulation of peroxisome proliferation
2.1. PPARα-controlled peroxisome proliferation — the classical scheme in
mammals
The capability of peroxisomes to proliferate in response to exoge-
nous stimuli has been described soon after their initial characteriza-
tion in 1965 by Hess and coworkers [14], who treated rats with the
hypolipidemic drug ethyl-chlorophenoxy-isobutyrate. However, it
took another 10 years to link the hypolipidemic effect of the further
on so-called “peroxisome proliferators” to peroxisomal fatty acid
β-oxidation [15] (see Chapter 4, this issue). Treatment of rodents
with classic peroxisome proliferators does not only result in a signif-
icant increase in organelle number, but also in changes in the perox-
isomal protein composition. Whereas enzymes involved in fatty acid
β-oxidation show an increase in both amounts and activities in
response to the stimulation, proteins involved in other tasks – e.g.,
the H2O2 detoxifying enzyme catalase – are irresponsive or even de-
creased. Importantly, different species respond with variable intensi-
ties to synthetic peroxisome proliferators: potent hypolipidemic
drugs such as ﬁbrates, induce peroxisome proliferation [14] and ex-
pression of β-oxidation enzymes [15], but also the formation of liver
tumors in rodent species [16]. Further studies showed that a massive
peroxisome proliferation upon treatment with peroxisome prolifera-
tors is only observed in Muridae, whereas other organisms, including
humans, are much more refractory [17] (see Section 2.2). Prolonged
treatment with peroxisome proliferators has a carcinogenic effect in
rodents leading to liver tumors [18–20] but apparently not in humans
[21]. After the nuclear receptor Peroxisome Proliferator Activated
Receptor α (PPARα), which belongs to the superfamily of steroid/
thyroid/retinoid receptors, was identiﬁed as the responsible mediator
for changing the expression of peroxisomal genes [22–24], it was pos-
sible to unveil that unsaturated long chain fatty acids are naturalligands of this receptor and thus transmit signals for the requirement
of enhanced lipid catabolism [25] (Fig. 1). Later on, two related nucle-
ar receptors, PPARγ and PPARβ/δ, were identiﬁed, which have partial-
ly overlapping substrate speciﬁcity but are not transmitting the
signals of classical peroxisome proliferators [23,24]. Notably, consti-
tutive expression of peroxisomal genes is not dependent on PPARα
since the corresponding knockout mice proved to be viable, fertile
and exhibit normal peroxisomes but are more susceptible to obesity
[26,27]. Synthetic compounds triggering peroxisome proliferation
via activation of PPARα are structurally remarkably different includ-
ing ﬁbrates, phthalate esters, polycyclic aromatic hydrocarbons, per-
ﬂuorooctanoate and related compounds or dehydroepiandrosterone.
Activation of PPARα does not only enhance the transcription of
peroxisomal genes implicated in fatty acid β-oxidation but also
those involved in peroxisome division, e.g. Pex11α (see Section 3.1,
Table 1). However, PPARα-dependent peroxisome proliferators are
capable of inducing peroxisome proliferation in a Pex11α knockout
mouse model thus pointing to a potential functional compensation
by the remaining Pex11 isoforms or to other, hitherto undetected
factors [28]. Like all nuclear receptors, PPARs have to form dimers to
attach to their correspondent DNA-binding sites (Fig. 1). For PPARα,
ligand-binding induces conformational changes which permit an inter-
action with Retinoid X Receptor-α (RXRα), thus building the activated
heterodimer capable of recognizing PPARα-responsive elements
(PPREs) (Fig. 1). PPREs have been reported for all peroxisomal
β-oxidation enzymes but also for several microsomal cytochrome
P-450 subtypes and for apolipoproteins types I and II [29]. Thus, besides
ligands for PPARα, full activation of the peroxisomal response depends
as well on binding of 9-cis-retinoic acid to RXRα [30]. Further, it was
shown that PPARα requires fatty acid-binding protein (FABP) for a full
response to peroxisome proliferators [31], whichmay act as a mediator
for nuclear transport of fatty acids.
2.2. Rats and mice are special — molecular background for species
differences
Concerning the species differences in peroxisome proliferation, the
afﬁnities of endogenous or exogenous ligands to PPARα were not
found to be responsible as was shown by experiments with species-
speciﬁc PPARαs and reporter constructs based on the rat PPAR
response element [32–34]. However, rats and mice exhibited a one-
magnitude higher expression level of PPARα in liver than humans or
guinea pigs [35,36], which would therefore allow a more frequent in-
teraction between receptor and ligand. Moreover, primates exhibit
signiﬁcant sequence differences in both PPARα response elements
and the corresponding DNA binding domain of the receptor, possibly
leading to differential activation of PPAR-controlled genes. Indeed,
insertion of murine response elements into human cell lines result in
a comparable activation of the peroxisomal ACOX1 gene, encoding
for acyl CoA oxidase 1, a key enzyme of peroxisomal β-oxidation
[37]. PPARα-humanized mice (the human PPARα was introduced
into the background of a PPARα knockout mouse line), however, still
show a mouse-like activation of β-oxidation activities, but do not de-
velop the proliferation-related tumors found in wild-type strains [38].
Thus, species differences in peroxisome proliferation appear to be
caused by a species-speciﬁc coevolution of PPARα and its DNA-
binding site elements allowing to adapt to individual physiological
needs which are at the moment still not completely understood.
2.3. PPARα and then? — new regulating factors emerge
Physiologically, PPARα appears to regulate peroxisome number
according to the requirements of increased lipolysis, e.g. in different
tissues from fasting or hibernating animals, where peroxisome num-
ber and PPARα expression are up-regulated in parallel [39–41]. In
brown adipose tissue, however, also PPARγ was suggested to
Fig. 1. Transcriptional regulation of peroxisome proliferation in different species. a) Mus musculus: Upon ligand binding, PPAR nuclear receptors and retinoid X receptors form
heterodimers and interact with their cognate response elements (PPRE). The transcriptional coactivator PGC-1α regulates peroxisome abundance in concert with a hitherto
unknown transcription factor. b) Saccharomyces cerevisae: Substrate-loaded heterodimers of the transcription factors Oaf1p and Pip2p induce transcription of peroxisomal genes
by binding to Oaf1p response elements (ORE). Adr1p binding to UAS1 response elements cooperatively enhances the transcription of corresponding genes. Adr1p binding may
be regulated by phosphorylation/dephosphorylation involving SNF1p. c) Aspergillus nidulans: The transcription factors FarA and FarB induce the transcription of peroxisomal
genes after binding long and medium chain fatty acids, respectively. d) Arabidopsis thaliana: Far-red light activates phytochrome A, which induces binding of the transcription factor
HYH to light responsible elements (LRE), e.g. in the promoter region of AtPex11b. See Section 2 for further details.
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peroxisome proliferation in brown adipose tissue during cold accli-
matization can be a PPARα-independent process involving the tran-
scriptional coactivator PGC-1α (peroxisome proliferator activated
receptor γ coactivator-1α) in humans and mice [42] (Fig. 1). Since
PGC-1α requires a DNA-binding transcription factor for mediating
its action [43], a hitherto unidentiﬁed transcription factor has to be
involved in the regulation of peroxisome numbers, since knockdown
of PPARα and known interactors of PGC-1α (e.g. ERRα, NRF2, Foxo1)
did not inﬂuence the PGC-1α-mediated proliferation. However, be-
sides PPARα also PPARγ and δ have been proposed to possess the ca-
pability to induce peroxisome proliferation [44]. Remarkably, PPARγ
has very recently been found to regulate peroxisome proliferation inhypothalamic neurons of mice on a fat-rich diet [45]. Subsequently,
peroxisome abundance modulates neuronal ROS concentrations
which inﬂuence the ﬁring rates of neurons in the hypothalamus and
by that the feeding behavior of the animals.
Besides PPAR-controlled proliferation, peroxisome numbers have
been shown to increase in mammals in response to various other
compounds, environmental factors or stimuli, which appear to be in-
dependent of this nuclear receptor. As a ﬁrst compound, BM 15,766
was shown to induce peroxisome proliferation without elevating per-
oxisomal β-oxidation implying that both processes can be regulated
independently [46]. Later, 4-phenylbutyrate was reported to induce
peroxisome proliferation in the absence of PPARα [47] proving that
there are other factors regulating peroxisome abundance. Growth
Table 1
Overview of the Pex11 proteins and their characteristics across species.
Model
organism
Protein
(size)
Transcriptional
regulation
Membrane
elongation
Membrane
association and
topology
Oligomerization Interaction
with Fis
Reference
Homo-oligomers Hetero-oligomers
H. sapiens Pex11α ✓ - TMD ✓ ✓ (αγ) ✓ [28,49,101–103,114,116,169,171]
(247aa) PPARα Ncyt/Ccyt IP IP IP
Pex11β n.d. ✓ TMD ✓ ✓ (βγ) ✓
M. musculus (259aa) Ncyt/Ccyt IP IP IP
Pex11γ n.d. ✓ TMD ✓ ✓ (αγ; βγ) ✓
(241aa) Ncyt/Ccyt IP IP IP
A. thaliana Pex11a
(248aa)
n.d. (✓) TMD ✓ ✓ (all) ✓ [98,119,121,123]
Ncyt/Cmatrix BiFC BiFC BiFC
Pex11b ✓ (✓) TMD ✓ ✓(all) ✓
(227aa) HYH Ncyt/Ccyt BiFC BiFC BiFC
Pex11c n.d. ✓ TMD ✓ ✓(all) ✓
(235aa) Ncyt/Ccyt BiFC BiFC BiFC
Pex11d n.d. ✓ TMD ✓ ✓(all) ✓
(236aa) Ncyt/Ccyt BiFC BiFC BiFC
Pex11e n.d. - TMD ✓ ✓(all) ✓
(231aa) Ncyt/Ccyt BiFC BiFC BiFC
S. cerevisiae Pex11p ✓ ✓ peripheral ✓ - n.d. [76–78,80,106,107,112,122,206]
(236aa) Oaf1p-Pip2, Adr1p CL, Y2H
Pex25a ✓ ✓ peripheral ✓ (✓) (25/27) n.d.
(394aa) Oaf1p-Pip2, Adr1p Y2H Y2H
Pex27 n.d. - peripheral ✓ (✓) (25/27) n.d.
(376aa) Y2H Y2H
A. nidulans Pex11 ✓ ✓ n.d. n.d. n.d. n.d. [88,113,207]
(235aa) FarA, FarB
Pex11B n.d. n.d. n.d. n.d. n.d. n.d.
(237aa)
Pex11C (✓) n.d. n.d. n.d. n.d. n.d.
(255aa) putative FarA, FarB
T. brucei Pex11 n.d. ✓ TMD ✓ - n.d. [108–110]
(218aa) Ncyt/Ccyt IP
GIM5A n.d. n.d. TMD (✓)
IP
✓ (5A/B) n.d.
(243aa) Ncyt/Ccyt IP
GIM5B n.d. n.d. TMD (✓) ✓(5A/B) n.d.
(241aa) Ncyt/Ccyt IP IP
Abbreviations: n.d., not determined; TMD, transmembrane domain; CL, crosslinking studies; cyt, cytosolic; IP, immunoprecipitation; Y2H, yeast-2-hybrid; BiFC, bimolecular
ﬂuorescence complementation;
a Note that Pex25 has recently been implied in the de novo formation of peroxisomes from the ER in H. polymorpha and S. cerevisiae [111,112].
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have been described to induce peroxisome elongation – a stage pre-
ceding proliferation (see Section 3) – in human HepG2 cells, a cell
line refractory to the treatment with classic peroxisome proliferators
[48,49]. Furthermore, peroxisome proliferation was reported in re-
sponse to a plethora of chemical compounds not likely to interact di-
rectly with PPARα, such as endosulfan [50], cyclophosphamid [51],
estrogenic compounds [52], acetyl salicylic acid [53] or dinitro-o-
cresol [54]. Currently, it is not understood, how the elevation of per-
oxisome numbers is transduced in response to these treatments.
The number of structurally different compounds may point to a
more general stress response activating a hitherto undescribed sig-
naling network. However, in speciﬁc cases also signaling cross-talk
between different nuclear receptors, as e.g. described for PPARα/
RXRα and estrogen receptor-α, may occur at the corresponding pro-
moter response elements [55,56]. Concerning ROS, the scenario lead-
ing to peroxisome proliferation may be even more complicated.
Reactive oxygen species have been implicated in modulating and
inﬂuencing several signaling networks which can have cell survival
or suicide functions [57] and are important messengers in pathologi-
cal events such as cancer formation [58]. Thus, ROS can activate a
multitude of different kinase networks and transcription factors
depending on molecule species and concentration. In this context it
is currently enigmatic by which factors and how peroxisomal abun-
dance is regulated. Peroxisomes are both ROS scavenging organelles
and potent ROS producers [59,60] (see Chapters 12 and 13, this
issue). Unraveling their contribution to and regulation by redoxsensitive signaling networks will be an important task for future
research.
2.4. Enhanced peroxisome numbers are associated with particular
diseases
In addition to induction by monocausal triggers, peroxisome
proliferation was also reported to be associated with several liver dis-
eases such as alcoholic and non-alcoholic steatosis as well as associated
cirrhosis, cholestasis, and the different forms of hepatitis [61,62]. As
these diseases do not mandatorily share a common etiologic back-
ground, the peroxisomal induction found may be caused by varying
changes in the metabolic regulation systems associated. The peroxi-
some proliferation observed could be a sign of fatty acid overﬂow acti-
vating PPARα in steatohepatosis. Hashimoto and colleagues [63]
showed a direct connection between disease formation and knock out
of PPARα in mice. Vice versa treatment of mice with PPARα agonists
was found to ameliorate liver steatosis [64,65]. Accordingly, down reg-
ulation of PPARα levels was observed in ethanol-infused rats as amodel
for alcoholic fatty liver disease [66,67]. Therefore, the elevated peroxi-
some levels accompanying the disease are unlikely to be caused by
PPARα-activation, but are likely mediated by hitherto undiscovered
signaling pathways. During alcoholic and non-alcoholic liver disease,
ROS are produced by enhanced β-oxidation rates which are induced
by an overﬂow of fatty acids in the liver [68,69]. Thus, peroxisome pro-
liferation may represent a compensatory reaction to detoxify these
harmful metabolites. However, numerous nuclear receptors and other
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[70] and accordingly, the observed peroxisomal response may be in-
duced by more than one causality.
A proliferation of peroxisomes in early disease stages of viral
hepatitis has also been reported in humans and rodents [71,72]. As
steatosis and increased ROS are common features observed in differ-
ent forms of viral hepatitis [73,74], the factors discussed earlier may
trigger peroxisomal responses in these diseases as well. Interestingly,
however, Dixit and coworkers [2] recently showed that the anti-viral
signaling protein MAVS is located, in addition to mitochondria, on
peroxisomes and that viral infection induced an elongation of the
compartment. This may be an initial step in peroxisome proliferation
which is associated with the need of an increase in peroxisomal
membrane surface, e.g. to facilitate MAVS signaling.
2.5. Peroxisome proliferation in fungi
In yeast, peroxisome proliferation has been exploited to identify
peroxisome biogenesis (PEX) mutants [75]. Like animals, yeast spe-
cies react with peroxisome proliferation upon growth on fatty acids
as sole carbon source and likewise, transcription of Pex11 genes is in-
duced [76,77]. Analogous to mammals, upon fatty acid stimulation
Saccharomyces cerevisae forms heterodimers of the transcription factors
Pip2 and Oaf1p – two proteins of the Zn-cluster family of transcription
factors – and thereby activates the transcription of peroxisomal genes
containing oleate-response elements (ORE) [78] (Fig. 1). Like PPARs,
Oaf1p possesses functional fatty acid-binding domains, although em-
bedded in a completely different molecular architecture [79]. Future
studies have to reveal if both protein classes indeed share common an-
cestors as proposed by the authors, or are an example for analogous co-
evolution. However, unlike in animal species additional proteins were
found to be involved in the process of transcriptional regulation of per-
oxisomal proliferation and protein expression (Fig. 1). Adr1p is an addi-
tional zinc-ﬁnger transcription factor sensing carbon status and
controlling expression of peroxisomal genes [80]. Adr1p binds to up-
stream activating sequence 1 (UAS1) promoter sites under glucose
depression and oleate induction conditions. UAS1 binding sites can be
frequently found in proximity to OREs. Indeed, binding of Adr1p to pro-
moters of peroxisomal genes enhances the afﬁnity of Pip2/Oaf1p het-
erodimers to these promoters thus multiplying the transcriptional
capacity of peroxisomal genes [81]. Currently, it is still unknown if the
regulation system found in S. cerevisae is conserved among methylo-
trophic and n-alkane utilizing yeast species, which require amoremod-
ular peroxisomal response. However, ORE-like response elements were
identiﬁed for peroxisomal genes of Candida tropicalis; furthermore,
Mpp1p, a transcription factor of the binuclear Zn-cluster protein family
with impact on peroxisome proliferation was described in Hansenula
polymorpha (see [78] for detail). Recently, with Mxr1p (methanol ex-
pression regulator 1), a homolog of Adr1p was found in Pichia pastoris
[82], whereas homologs in higher eukaryotes have not been described
yet. Thus, methyl-induced peroxisome proliferation in the methylo-
trophic yeast P. pastoris seems to rely on a regulative mechanism which
is conserved in different yeast species. Snf1p is an AMP-activated protein
kinase found to be required for peroxisome proliferation in Sacchero-
myces cerevisae [83] (Fig. 1). Gurvitz and Rottensteiner hypothesized
that Snf1p could be a kinase activating Oaf1p by phosphorylation [78].
However, although a phosphorylation of Oaf1p was detected, it was not
abolished in a ΔSnf1-strain [81]. Recently, it was shown that Adr1p acti-
vation is controlled by dephosphorylation of Ser230 and that this event is
dependent on Snf1p [84,85]. The authors hypothesize that Snf1p could
accomplish this task by phosphorylation-dependent activation of a corre-
spondent phosphatase or inhibition of a kinase responsible for Ser230
phosphorylation. In animals AMP-activated kinase (AMPK) is the homo-
log of Snf1 [86], but a direct inﬂuence on peroxisome proliferation has yet
not beendescribed. Inﬁlamentous fungi, FarA and FarB, two transcription
factors of the Zn2Cys6 class, have been found to induce the transcriptionof genes implicated in fatty acid degradation as well as peroxisome
biogenesis [87,88] (Fig. 1). Orthologs of these genes were found in
ascomycetes [89,90], but also in several hemiascomycetes [91]. As
described earlier, in other hemiascomycetes like Saccharomyces these
transcription factors were replaced by the Pip2p/Oaf1p system.
2.6. Peroxisome proliferation in plants
In plants, ROS, UV radiation, salt stress, and even cloﬁbrate, de-
spite the lack of PPARs, are potent inducers of peroxisomal prolifera-
tion [92–95]. However, the molecular mechanisms regulating these
processes remain enigmatic. In Arabidopsis thaliana treatment with
cloﬁbrate and wounding exhibit a similar activation of peroxisomal
β-oxidation genes suggesting a regulation by jasmonate signaling in
both cases. However, both phenomena showed no signs of intercon-
nection since wounding and jasmonate treatment did not lead to de-
tectable peroxisome proliferation [96]. In addition, induction of
peroxisome proliferation was shown in response to light exposure
in A. thaliana. During this process, glyoxysomes of seedlings involved
in lipid metabolism are remodeled to leaf peroxisomes inhabiting en-
zymes of the glycolate pathway [97]. For this phenomenon a ﬁrst reg-
ulatory mechanism was recently reported [98]: Like in animals and
yeast, Pex11 and dynamin-related proteins are involved in peroxi-
somal elongation and division at the organelle level [99] (see
Sections 3 and 4). In Arabidopsis light induces the expression of the
Pex11-isoform Pex11b, which subsequently triggers peroxisome
elongation thus initiating peroxisome division. This process was
found to be mediated by the photoreceptor phytochrome A (phyA),
which upon far-red light exposure translocates from the cytoplasm
to the nucleus, where it interacts with transcription factors to activate
light inducible genes [100] (Fig. 1). Further, the bZip transcription fac-
tor HYH, a downstream signaling component for several photorecep-
tors, was shown to bind directly to the Pex11b promoter and appears
to be the direct transcriptional activator involved in light-induced
peroxisome proliferation.
Taken together, individual control systems for peroxisome prolifera-
tion have emerged in all branches of the phylogenetic tree, which de-
pend on similar but also diverging regulative concepts. To gain a more
detailed understanding on how individual stimuli inﬂuence and regu-
late peroxisome abundance under physiological and pathological condi-
tions, future investigations are required. To shed light on the relevance
of peroxisome plasticity in health and disease, it will be important to un-
ravel further interconnections between the numerous cellular signaling
networks and the peroxisomal division machinery, e.g. with the various
Pex11 isoforms found to be conserved across organisms.
3. Peroxin 11 (Pex11p) proteins
The peroxin 11 (Pex11) family is comprised of a number of con-
served membrane proteins in fungi, plants and mammals that have
been proposed to control peroxisome proliferation, and to function
in the regulation of peroxisome morphology, size and number
[49,76,77,101,102] (Table 1). Although Pex11 proteins are generally
considered as key components of peroxisomal ﬁssion or division,
they do not perform ﬁnal membrane scission, which depends on
dynamin-like proteins (DLPs/DRPs) (see Section 4). It is thought
that Pex11 proteins mediate the initial step(s) of peroxisomal divi-
sion and proliferation that is the growth and enlargement of the per-
oxisomal compartment (see Sections 3.2 and 3.3) prior to ﬁssion. In
line with this, Pex11 proteins are supposed to recruit or assemble fur-
ther components of the division machinery, e.g. Fis1, and thus DLPs
(see Section 4). Loss of Pex11 function generally results in a decrease
in peroxisome number and presence of enlarged peroxisomes,
whereas overexpression of Pex11 leads to peroxisome elongation,
subsequent division and an increase in peroxisome abundance. How-
ever, it should be noted that not all Pex11 isoforms in a given species
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pointing to distinct functions in peroxisome biogenesis (see later dis-
cussion). In line with this, the membrane association and topology of
Pex11 may vary in different organisms (Table 1). Furthermore, not all
Pex11 proteins can complement each other, although there is partial
redundancy. It was recently reported that tagged variants of Pex11
proteins from plants, yeast and mammals are properly targeted to
peroxisomes in plant and human cells and result in peroxisome pro-
liferation when heterologously expressed [103].
3.1. Pex11 isoforms and Pex11-related proteins
While Pex11p (originally termed PMP31/32 according to its de-
duced molecular mass of approx. 30 kDa) was initially identiﬁed in
C. boidinii as an inducible membrane protein upon peroxisome prolif-
eration [104,105], its functional signiﬁcance in this process was only
recognized after deletion of its homolog in S. cerevisae, which led to
the generation of one or two giant peroxisomal structures [76,77].
Conversely, overexpression was shown to result in peroxisome elon-
gation and an increased number of small peroxisomes [76,77]. Be-
sides Pex11, additional proteins with weak sequence similarity to
Pex11 (so called Pex11-related or Pex11-like proteins) have been
identiﬁed, mainly in S. cerevisae, and added to the Pex11 family
(Table 1). These include the oleic acid-inducible Pex25p and the
non-inducible Pex27p, whose deletions also inﬂuence peroxisome
maintenance in S. cerevisae [106,107], as well as GIM5a and GIM5b,
two Pex11-like proteins in Trypanosoma brucei [108–110]. Recently
it was reported that Pex25p unlike Pex11p is involved in de novo for-
mation of peroxisomes from the ER [111], whereas Pex27p appears to
be a negative regulator of peroxisome proliferation [112]. Some yeast
species like Candida albicans, Yarrowia lipolytica, Hansenula polymor-
pha or Debaryomyces hensenii contain Pex11C, another isoform with
higher similarity to ScPex11p, thus resembling the situation in higher
eukaryotes, where more than one isoform is present [113] (Table 1).
In mammals, for example three Pex11p isoforms were shown to con-
trol peroxisome proliferation under both basal and induced condi-
tions: Pex11pα, Pex11pβ and Pex11pγ [28,49,101,102,114–117].
This situation is analogously found in ﬁlamentous fungi, where as
well three Pex11 isoforms, Pex11A-C, have been identiﬁed [113]
(Table 1). In the ﬁlamentous fungus Aspergillus oryzae, Pex11 proteins
not only induce peroxisome proliferation but were also reported to
control the organelles' differentiation into Woronin bodies, a special-
ized peroxisomal derivate [118]. In themodel plant Arabidopsis thaliana,
even ﬁve obvious homologs were discovered, termed Pex11a-e [119]
and categorized into three subfamilies: Pex11a, Pex11b and Pex11c-e
(the latter showing the highest similarity to ScPex11p) [120]
(Table 1). Thus, multiple Pex11 isoforms and/or related proteins ap-
pear to exist in all eukaryotes pointing to a functional variability in
the process of peroxisome proliferation. In plants, despite some func-
tional redundancy between the isoforms – as deletions of only a
Pex11 subset has no obvious effect on plant physiology – differences
in the expression pattern of the isoforms and in the morphological
changes upon overexpression have been described [119,121]. Inter-
estingly, not all isoforms induce peroxisome proliferation: only ex-
pression of Pex11a and Pex11e was reported to increase peroxisome
number, whereas Pex11c and Pex11d induce peroxisome elongation
without subsequent ﬁssion. Unlike the other forms, Pex11e was
found to duplicate peroxisomes without any prominent membrane
elongation, whereas Pex11b induced peroxisome aggregation [119].
Likewise, in mammals different expression patterns were ob-
served for the three isoforms. While Pex11pβ is constitutively
expressed, both Pex11pα and Pex11pγ show tissue-speciﬁc expres-
sion, but are most prominent in the liver [28,49,114,115,117]. More-
over, they differ in their transcriptional regulation: Pex11pα is a
cloﬁbrate-inducible protein in rat, while the related Pex11pβ was
identiﬁed as its non-inducible homologue, sharing 40% sequencesimilarity [101]. In line with this, the Pex11pα gene is regulated by
PPARα (see Section 2.1)[116], but is dispensable for PPAR-α mediat-
ed peroxisome proliferation in Pex11pα knockout (KO) mice suggest-
ing functional redundancies between the three isoforms [28].
Regarding peroxisomemorphology, there is a profound difference be-
tween Pex11pα, Pex11pβ and Pex11pγ-mediated peroxisome prolif-
eration since only the latter two induce a pronounced peroxisome
elongation prior to ﬁssion (Table 1)[49,114]. Concerning their func-
tional importance, KO of Pex11pα in mice showed no obvious pheno-
typic alterations – except for some clustering of liver peroxisomes –
suggesting functional compensation by the other isoforms. The KO
of Pex11pβ, however, led to neonatal lethality and a Zellweger-like
phenotype [28,114].
Across species all hitherto identiﬁed Pex11 isoforms are tightly
associated with the peroxisomal membrane (Table 1). However,
whereas the S. cerevisae proteins appear to be peripherally associated
[77,106,107,122], mammalian and plant forms possess 1–2 or 3–4 pre-
dicted membrane spanning helices, respectively [49,101,102,119,121],
with both the C- and N-termini (with exception of the plant Pex11a)
protruding into the cytosol (Table 1).
All Pex11 forms hitherto identiﬁed including the Pex25 and Pex27
proteins found in most yeast species form homodimers and except for
Pex11p in S. cerevisae and Pex11α/β in mammals can also heterodi-
merize with each other (Table 1) [103,106,107,122,123]. Homooligo-
merization of ScPex11p has been proposed to inhibit Pex11p function
in peroxisome division [122], but the functional signiﬁcance of homo-
and heterooligomerization in other species remains to be determined.
3.2. Pex11-mediated membrane elongation and membrane remodeling
Studies with mammalian cell cultures expressing Pex11β initially
revealed that peroxisome proliferation follows a multistep process in-
cluding peroxisome membrane elongation (tubulation), membrane
constriction, and ﬁnal membrane ﬁssion (Figs. 2, 3) 1996 [49] . This
model for peroxisomal “growth and division” is now generally ac-
cepted [5,6,99,124–127]. It should be noted that the aforementioned
dynamic morphological changes of peroxisomes can as well be ob-
served under routine culture conditions and in animal models for per-
oxisome proliferation [6]. Interestingly, Pex11β was observed to
promote membrane elongation and to concentrate at the constriction
sites [49], thus being the ﬁrst peroxisomal membrane protein de-
scribed to display a non-uniform membrane distribution (Fig. 3).
We recently discovered that a Pex11pβ-YFP fusion protein can be
used as a speciﬁc tool to further dissect the peroxisomal growth and
division pathway by blocking peroxisome division at an early stage
[128]. Expression of Pex11pβ carrying a monomeric YFP tag at the
C-terminus inhibited constriction and division of peroxisomes in
mammalian cells, but instead resulted in the formation of elongated
pre-peroxisomal membrane structures, so called TPAs (tubular per-
oxisomal accumulations). In a similar study, the transient expression
of various Pex11 family members led to the formation of protrusions
which developed into large peroxisomal membrane stacks, termed
juxtaposed elongated peroxisomes (JEPs) [103]. The JEPs, however,
formed microtubule-dependent and disappeared after overexpres-
sion of Fis1, but not DLP1. As the division of the TPAs was blocked,
single peroxisomes were apparently depleted from the cells. This ob-
servation challenges the current view that de novo formation from the
ER and division of pre-existing peroxisomes may occur simultaneous-
ly in mammalian cells [10,129]. We might face a situation similar to
yeast, where only the complete loss of peroxisomes triggers de novo
formation [130]. Ultrastructural studies revealed that the pre-
peroxisomal membrane compartment induced by Pex11pβ-YFP was
composed of globular and extended tubular membrane domains. In-
terestingly, peroxisomal matrix proteins and PMPs distributed to dis-
tinct regions of the peroxisomal structures: matrix proteins and some
PMPs (e. g. those with metabolic functions) were mainly targeted to
Fig. 2. Key ﬁssion proteins on peroxisomes and mitochondria in mammals. Peroxisomes and mitochondria share key components of their ﬁssion machineries. DLP1 is a GTPase
performing the ﬁnal scission of constricted membranes and is recruited to the organelle from the cytosol by the tail-anchored membrane receptors Mff and Fis1. Whereas Mff
appears to be the essential DLP1 receptor for organelle ﬁssion, Fis1 might fulﬁl regulatory functions. On peroxisomes, the peroxin Pex11pβ that is known to regulate peroxisome
abundance and to elongate membranes prior to ﬁssion, is supposed to interact with Fis1, which might result in the assembly and/or recruitment of other components of the ﬁssion
machinery. On mitochondria, the N-terminally anchored proteins Mid51 and Mid49 may sequester DLP1 thus inhibiting its function. Fis1 can potentially regulate the inhibitory
effect of MiD51 on DLP1 function and mitochondrial ﬁssion (see Section 4.3 for details). In yeast and plants additional receptor and adaptor proteins have been identiﬁed which
are involved in mitochondrial and peroxisomal division (see Table 2).
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biogenesis (Pex16p, Pex19p, Pex3p) were uniformly/evenly distribut-
ed, whereas the majority of Pex11pβ and Fis1 localized to the tubular
membrane domains (Fig. 3) [128]. These ﬁndings point to speciﬁc, yet
undeﬁned sorting and retention mechanisms within the peroxisomal
membrane which require further investigation. Interestingly, a role
for lipid rafts in peroxisome biogenesis has recently been proposed
[131].
We as well demonstrated that Pex11pβ initially localizes to pre-
existing spherical peroxisomes, where it induces the formation of a
nose-like membrane protrusion which further extends resulting in a
membrane tubule (Fig. 3). Again, these ﬁndings support the view
that Pex11pβ is a peroxisome morphology protein that can shape
and deform the peroxisomal membrane.
By applying the HaloTag technology for sequential labeling of
catalase, we provided evidence that the membrane tubules contain
only newly synthesized catalase, whereas pre-imported catalase is
found in the spherical (mature) membrane compartment. Theseﬁndings extend our previous model indicating that Pex11pβ-
mediated growth (elongation) and division of peroxisomes follows
a multistep maturation pathway, which is initiated by the formation
of an early peroxisomal membrane compartment from a pre-
existing peroxisome and its stepwise conversion into a mature, met-
abolically active peroxisome compartment (Fig. 3). Maturation is
achieved by selective and stepwise import of certain PMPs, mem-
brane lipids and matrix proteins. Our observations support the view
that peroxisome division is an asymmetric process [132,133], which
is far more complex than simple (symmetric) division of a pre-
existing organelle. Interestingly, a maturation model is also proposed
for de novo formation of peroxisomes from the ER [8,134].
Complementary to those ﬁndings, another recent study in H.
polymorpha implied that Pex11p plays a key role in membrane reor-
ganization prior to ﬁssion [135]. In ﬁssion arrested, Dnm1-deletion
cells, tubular extensions protrude from the mother peroxisome, which
show a differential distribution of membrane proteins with speciﬁc
peroxins in the tubule (e.g. Pex8p, Pex10p, Pex14p, Pex25p), while
Fig. 3.Model of peroxisomal growth and division in mammalian cells. A well deﬁned sequence of morphological changes of peroxisomes, including elongation (growth), constric-
tion, and ﬁnal ﬁssion (division) contributes to peroxisome proliferation in mammalian cells. Targeting to and/or activation of Pex11pβ at pre-existing peroxisomes initiates mem-
brane remodeling and the formation of a tubular membrane extension on one side of the peroxisome. (a) Peroxisomal membrane remodeling via Pex11p is induced by the insertion
of an amphipathic helix into one leaﬂet of the lipid bilayer which causes membrane asymmetry and bending (based on data obtained with HpPex11p). Homodimerization may keep
Pex11p in an inactive form (see Section 3.3 for details). Subsequently, the extension grows and acquires a speciﬁc set of PMPs (e.g. Pex11pβ, Fis1), before it constricts and starts to
import predominantly newly synthesized matrix proteins. Pex11pβ and the Mff-DLP1 complex concentrate at the sites of constriction, possibly driven by alterations in membrane
curvature. (b) Cytosolic DLP1 is recruited by the membrane receptor Mff. After targeting, DLP1 self-assembles into large ring-like structures that hydrolyze GTP and sever the per-
oxisomal membrane. Fis1 may fulﬁl a regulatory function. Proper intracellular distribution of peroxisomes formed by division requires microtubules and motor proteins. It should
be noted that elongated peroxisomes in mammalian cells can form and divide independent of microtubules and are even induced by microtubule-depolymerizing agents [172].
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tion studies indicated that Pex11p and speciﬁcally its N-terminal do-
main plays a key role in the acquisition and maintenance of the
differential distribution of the PMPs. Ultrastructural studies suggest
that initially a number of vesicular membrane structures are formed
in a Pex11-dependent manner at the base of the Pex11p accumulation
and that the membrane extension is formed out of these vesicles by
the action of the myosin motor Myo2 and the peroxisomal inheritance
protein Inp2 generating a pulling force [135]. This direct linkage be-
tween peroxisome proliferation and cell division in H. polymorpha
may further explain the failure to retain peroxisomes in the mother
cells upon deletion of HpPEX11 [136].
3.3. Mechanism of Pex11-induced membrane elongation
The biochemical properties of Pex11p have long been a matter of
debate [125], but a recent study in P. crysogenum provided insight
into the mechanism of Pex11p-induced membrane elongation [137].
Sequence comparison of yeast, fungal and human Pex11p isoforms
revealed the presence of several conserved N-terminal helical motifs
with amphipatic properties (i.e. hydrophobic and polar amino acids
are segregated between the opposite faces of the α-helix). This distri-
bution is well-suited for membrane binding and a model amphipathic
helix adopts an orientation parallel to the membrane plane, inserting
its hydrophobic residues between the fatty acyl-chains and its polar
residues towards lipid polar heads of one leaﬂet, ultimately inducing
membrane bending (Fig. 3) [138]. Within Pex11p, the so-called H3
motif formed the most extended helix in all species analyzed and de-
rived peptides termed Pex11-Amphwere used for further studies. Ex-
periments using small unilamellar lipid vesicles (SUVs) revealed that
Pex11-Amph peptides derived from different species preferentially
bind to negatively charged SUVs that resemble the phospholipid com-
position of peroxisomes, inducing their tubulation. Notably, the tubu-
lation induced by HsPex11pα was not as prominent, which is in line
with previous ﬁndings [102]. Mutation analyses determined that the
conservation of the amphipathic properties and the helix-formingabilities are essential for tubulation. The mechanical membrane-
bending capabilities of the shared amphipatic helix motifs may fur-
ther explain the reported complementing effects of heterologously
expressed Pex11 proteins across species [103]. Additionally, the en-
tire N-terminal domain of Pex11p was shown to exert membrane
remodeling capacity, which was conﬁrmed in vivo in H. polymorpha.
However, open questions remain in regard to the regulation of
Pex11 activity. Early studies in S. cerevisiae provided evidence for
dimerisation in later growth stages, indicating that Pex11p may act
as a monomer whose action is blocked upon dimerisation (Fig. 3)
[122]. Furthermore, ScPex11p contains cysteine residues of which
the most N-terminal one – intriguingly indicated to be positioned in
an amphipathic helix – was shown to affect dimer formation, thus
providing a potential redox-sensitive conformational switch [122].
Besides regulation on the transcriptional and translational level,
ScPex11p activity was recently shown to be inﬂuenced by post-
translational modiﬁcation [139]. ScPex11p was shown to be phos-
phorylated at S165/167, and the expression of phospho-mimicking
mutants resulted either in a hyper-proliferative phenotype (Pex11-
D “on”) or in few and clustered peroxisomes (Pex11-A “off”) resem-
bling a deletion phenotype. Furthermore, overexpression of the
cyclin-dependent kinase Pho85p resulted in hyperphosphorylation
of Pex11p.
In contrast to higher eukaryotes, yeasts contain additional peroxins
which inﬂuence peroxisome maintenance by interaction with or inde-
pendent of Pex11 proteins. Deletion of the integral membrane proteins
ScPex28 and ScPex29 (Pex24 in Y. lipolytica) led to the formation of
clustered peroxisomes, thus implying a function in organelle separation
[140]. ScPex30p, ScPex31p and ScPex32p were also reported to inﬂu-
ence peroxisome numbers [141,142]. Deletion of Pex30, however, re-
sults in an increase in peroxisome number, implying a function as a
negative regulator. The integral membrane protein ScPex34p, which
acts independently, but also in concert with ScPex11p, ScPex25p and
ScPex27p, increases peroxisome numbers when overexpressed [143].
In mammals, Pex11pα, β and γ are so far the only peroxins known to
regulate peroxisome number and abundance.
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Whereas the role of Pex11 proteins in peroxisome proliferation
has been linked to membrane elongation and deformation, it has be-
come evident in the last years that ﬁnal membrane scission of perox-
isomes in all organisms studied so far depends on the assembly of
dynamin-like (−related) proteins (DLPs/DRPs) at the peroxisomal
membrane (Table 2). DLPs are large GTPases with mechanochemical
properties that belong to the dynamin superfamily, whose members
participate in various cellular membrane ﬁssion and fusion events
[144]. DLPs are supposed to assemble into higher ordered ring-like
structures in a GTP-dependent manner that wrap around membrane
tubules to sever the membrane in a GTP hydrolysis-dependent pro-
cess (Fig. 3) [145,146]. A recent cryo-electron microscopy study
[147] revealed that S. cerevisae Dnm1 can form spirals with a much
wider diameter (approx. 100 nm) than classical dynamins, that act
in endocytosis (approx. 20 nm). However, the presence of other fac-
tors that may help to constrict the organelle membrane at deﬁned
sites to support assembly of DLPs in vivo is discussed [148]. DLPs con-
tain a GTPase domain, followed by a middle domain and a GTPase ef-
fector domain, but they are lacking the proline rich domains and
pleckstrin-homology domains (implicated in membrane binding)
found in classical dynamins. With the majority present in the cytosol,
DLPs have to be recruited to the peroxisome membrane for division.
In mammals, the tail-anchored membrane receptor proteins Fis1 and
Mff are supposed to provide an anchoring site for DLP1 [149–151]
(Table 2) (Fig. 2). In S. cerevisae, peroxisome division depends on Fis1
and the WD40 domain-containing adaptor proteins Mdv1 and Caf4
[152,153], which are supposed to recruit Dnm1 to the peroxisomal
membrane (Table 2). Furthermore, the DLP ScVps1, which is recruited
by Pex19p, mediates peroxisome division in a Fis1-independent man-
ner [154,155]. Mammalian homologs of Mdv1 and Caf4 have not been
identiﬁed, and expression of Mff appears to be restricted to metazoans.
In plants, DRP3A is recruited to peroxisomes by Fis1B [123,156]; how-
ever, PMD1 (Peroxisomal and Mitochondrial Division Factor 1), a
plant-speciﬁc protein with a potential function in peroxisomal and mi-
tochondrial division and/or positioning has recently been identiﬁed
(Table 2) [157]. Interestingly, like Mff, PMD1 is supposed to be a tail-
anchored membrane receptor containing coiled-coil domains. Despite
these species-speciﬁc differences, it has been demonstrated that in
many organisms peroxisomes andmitochondria share key components
of the same DLP-based ﬁssion machinery (Table 2). Remarkably, shar-
ing these components appears to be a common, evolutionary conservedTable 2
Shared key components of peroxisomal and mitochondrial ﬁssion across organisms.
Mammals
Function Domain Peroxisomes Mito
Membrane receptor (DLP1 recruitment) C-TA Fis1 Fis1
TPR repeat
Membrane receptor (DLP1 recruitment) C-TA Mff Mff
Coiled-coil
Membrane receptor (segregation?) C-TA - -
Coiled-coil
Membrane receptor (DLP1 sequestration) N-TA - MiD
MiD
Adaptor protein WD 40 ? ?
Others
Membrane scission Large GTPase DLP1/Drp1 DLP1
Abbreviations: C-TA, C-terminally tail-anchored; TPR, tetratricopeptide repeat; N-TA, N-ter
a Recent work has suggested the existence of WD40 proteins with a similar domain str
At3g18860, At4g05410, At4g21130, At5g50230, At5g67320). The proteins share a central co
ever, further studies need to determine localization and function [156].
b Note that Caf4 proteins appear to be only present in S. cerevisiae and C. glabrata. Similarly, a
Vps1 is not present in other yeast species such as H. polymorpha [204,205]. Besides a role i
c DRP5B mediates the division of both peroxisomes and chloroplasts [208].strategy used by mammals, fungi and plants [6,158]. Moreover, these
ﬁndings have further strengthened the disease-relevant concept of the
“peroxisome-mitochondria connection” (see Section 4.2.1) [159] indi-
cating that peroxisomes and mitochondria exhibit a much closer func-
tional interplay than previously anticipated [158,160]. It is now
evident that these organelles, besides metabolic cooperation in fatty
acid β-oxidation in animals, also share a redox-sensitive relationship
(see Chapter 12, this issue) and cooperate in anti-viral signaling [161]
Furthermore, a novel vesicular trafﬁcking pathway betweenmitochon-
dria and peroxisomes has been proposed [162].
4.1. Do peroxisomes fuse?
In contrast to mitochondrial dynamics, which are regulated by
balanced fusion and ﬁssion events [163–165], only peroxisomal ﬁs-
sion events have so far been reported. There is ﬁrm evidence that ma-
ture peroxisomes in yeast and mammals do not fuse in a mechanism
similar to mitochondrial fusion [130,132,166]. In line with this, mito-
chondrial fusion proteins such as the dynamin-related GTPases Mfn1
and Mfn2, or OPA1 were not found to localize to mammalian peroxi-
somes [166]. Interestingly, live cell imaging revealed that peroxi-
somes are engaged in transient and long term contacts, but without
exchanging matrix or membrane markers [166]. However, fusion of
peroxisomal subcompartments has been described as part of peroxi-
somal maturation in the yeast Y. lipolytica [167] that is mediated by
the peroxins Pex1p and Pex6p. Furthermore, in live cells, reticular net-
works of peroxisomes have been described, which are extremely dy-
namic, with constant formation of tubular extensions interconnecting
or detaching [168]. Thus, it can currently not be rigorously excluded
that under certain metabolic or environmental conditions peroxisomes
fuse to formmore complex and dynamic structures to fulﬁl specialmet-
abolic functions more efﬁciently. However, these processes likely differ
from mitochondrial fusion events.
4.2. Peroxisomal division in human diseases
4.2.1. DLP1 deﬁciency
Studies with mammalian cell cultures have revealed that functional
loss of DLP1 (e.g. by siRNA-mediated silencing or the expression of
dominant-negative mutants) inhibits peroxisomal (andmitochondrial)
ﬁssion resulting in an elongated organelle morphology [148,169–171].
Interestingly, the elongated peroxisomes in DLP1 silenced cells exhibit
a segmented, “beads on a string”-like morphology [148,172] (Fig. 3)Plants Yeast
chondria Peroxisomes Mitochondria Peroxisomes Mitochondria
Fis1a, b Fis1a, b Fis1p Fis1p
- - - -
PMD1 PMD1 - -
49 - - - -
51/MIEF1
Othersa ELM, othersa Mdv1 Mdv1
Caf4b Caf4b
/Drp1 DRP3A, B DRP3A, B Dnm1 Dnm1
DRP5Bc DRP1C, E Vps1b
minally tail-anchored.
ucture as Mdv1/Caf4 in the Arabidopsis genome (At1g04510, At2g32950, At2g33340,
iled-coil domain and a WD40 repeat region and range from 450–900aa in length. How-
lthough required for peroxisome division under glucose-grown conditions in S. cerevisiae,
n peroxisome division, Vps1 is as well involved in vacuole formation.
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ﬁnal membrane scission. The factors that support constriction of the
peroxisome membrane at deﬁned sites to support assembly of DLP1
are still unknown.
Based on the reported peculiar peroxisome morphology in DLP1
silenced cells [148,170], a novel lethal disorderwith defects in both per-
oxisomal and mitochondrial ﬁssion due to a heterozygous, dominant-
negative missense mutation (A395D) in the middle domain of DLP1
was identiﬁed [173]. A recent biochemical study demonstrated that
this mutation inhibits higher order assembly of DLP1 [174]. Other mid-
dle domain mutations (e.g. C452F; G363D, which may interfere with
GTP hydrolysis) [175,176] or mutations in the GTPase domain (e.g.
K38A, which inhibits GTP hydrolysis, but not GTP binding) are as well
known to block DLP1 function leading to an elongated organelle
morphology [170,171].
DLP1 deﬁciency represents the ﬁrst member of a new group of
combined peroxisomal–mitochondrial disorders. Its discovery further
supports the concept of the “peroxisome–mitochondria connection”
(see Section 4) [159]. The female patient, who died only few weeks
after birth, showed microcephaly, abnormal brain development,
optic atrophy and hypoplasia [173]. Several of the abnormalities
were broadly similar to known disorders related to mitochondrial dy-
namics (e.g. Charcot–Marie–Tooth neuropathy, autosomal dominant
optic atrophy), but the clinical course was more severe. Furthermore,
elevated plasma levels of lactate and very-long chain fatty acids were
detected pointing to defects in both mitochondrial and peroxisomal
functions (mitochondrial respiration and peroxisomal β-oxidation,
respectively). Elongated, constricted peroxisomes (and elongated mi-
tochondria) similar to the ones described after loss of DLP1 function
were observed in skin ﬁbroblasts from the patient. Thus, the analysis
of peroxisomal (and mitochondrial) morphology in patient cells is a
valuable diagnostic tool for the determination of disorders based on
defects in peroxisomal (mitochondrial) division.
The aforementioned ﬁndings have recently been conﬁrmed by the
generation and characterization of complete and brain-speciﬁc DLP1
knockout mice [177,178]. Complete knockouts displayed develop-
mental abnormalities that resulted in embryonic lethality. Further-
more, peroxisomes and mitochondria exhibited an elongated and
constricted morphology, thus conﬁrming siRNA and mutational stud-
ies in cell culture. DLP1 function appears to be physiologically impor-
tant for synapse formation and brain development in mice (for
example by producing mitochondria, whose size is compatible with
their movement and proper distributed within neurons). Despite
the dramatic changes in mitochondrial morphology and dynamics,
loss of DLP1 had no effect on mitochondrial respiration and ATP pro-
duction. However, a C452F mutation in the DLP1 middle domain has
been reported to result in dilated cardiomyopathy in mice [175].
It is presently unclear to what extent defects in mitochondrial or
in peroxisomal function contribute to the clinical phenotype of the
patient and to the pathological alterations observed in the knock
out models. With respect to the functional interplay between peroxi-
somes and mitochondria (see Section 4), and the important role of
peroxisomes in brain development and neurodegenerative diseases
[179–181], the contribution of peroxisomes to the observed patho-
physiologies should not be underestimated. In addition, DLP1 may
fulﬁll additional functions in other subcellular locations. We have
recently localized DLP1 at the Golgi complex in distinct cell types
(but not in human ﬁbroblasts), and proposed a role as a novel compo-
nent of the apical sorting machinery at the trans-Golgi network [182].
In addition, cell-type speciﬁc requirements of DLP1 for mitochondrial
division (e.g. in Purkinje neurons and granule cells) have been sug-
gested [178]. Finally, DLP1 activity is highly regulated through a num-
ber of post-translational modiﬁcations including phosphorylation,
S-nitrosylation, ubiquitination and sumoylation). If and how these
modiﬁcations inﬂuence peroxisome dynamics and function has not
yet been addressed. However, altered DLP1 activity via post-translational modiﬁcations is supposed to change mitochondrial
dynamics in the course of neurodegenerative disorders [183,184].
4.3. The receptor proteins Fis1 and Mff
The potential receptor proteins for DLP1 on peroxisomes, Fis1
(Fission factor 1) and Mff (Mitochondrial ﬁssion factor) are both
C-tail anchoredmembrane proteins, that are sharedwithmitochondria
(Figs. 2, 3) (Table 2) [149,150,169]. Fis1 was identiﬁed in mammals
based on sequence homology to ScFis1p and has been suggested to
recruit DLP1 to mitochondria and peroxisomes [150,169,185–188].
Fis1 possesses an N-terminal tetratricopeptide repeat (TPR) domain,
whereas Mff exposes its N-terminal part with a central coiled-coil
motif into the cytosol [149,188]. Fis1 homodimerizes, which appears
to be necessary for its function in organelle division [189]. Mff is sup-
posed to act in a complex different from Fis1 [149].
Overexpression of Fis1 promotes peroxisomal (and mitochondrial)
fragmentation, while silencing of Fis1 has been reported to result in
elongated peroxisomes (and mitochondria) indicating that organelle
division is blocked [150,169,187,188,190,191]. Furthermore, Fis1 was
shown to be targeted to peroxisomes in a Pex19p-dependent manner
[192] and to localize to highly puriﬁed peroxisomal fractions [150].
However, the effect of Fis1 silencing on peroxisome morphology was
less pronounced than silencing of DLP1 [150]. Whereas DLP1 localizes
in spots to potential division sites [188] (Fig. 3), Fis1 distributes uni-
formly over the peroxisomal (and mitochondrial) membrane, which
does not quite ﬁt to its proposed role as major membrane receptor for
DLP1. In line with this, DLP1 can still be recruited to mitochondria fol-
lowing knockdown of Fis1 [186,193]. Moreover, targeted knockdown
of Fis1 in mammalian cells was recently reported to have little if any
effect on mitochondrial and peroxisomal morphology, and it was pro-
posed that previous observations made through RNAi studies were
the result of off-target effects [151]. Morphological alterations of perox-
isomes after modulation of Fis1 expression levels might as well be
indirectly induced by mitochondrial alterations (e.g. via functional
peroxisome-mitochondria interplay; see Section 4) [159,160]. Based
on these contradictory ﬁndings, the role of Fis1 as the main receptor
for DLP1 in mammals and its contribution to organelle ﬁssion has re-
cently been questioned [194] and it has been suggested that other pro-
teins are involved in recruiting DLP1 tomitochondria and peroxisomes.
There is growing evidence now thatMff is an essential factor for recruit-
ing DLP1 to prospective ﬁssion sites on mitochondria and peroxisomes
[151] (Fig. 2; Table 2). Loss of Mff function by RNAi results in elongated
peroxisomes (andmitochondria) similar to silencing of DLP1 [149,151].
Furthermore, the elongated peroxisomes formed after silencing of
Mff exhibit a constricted morphology as reported for silencing of DLP1
[148,170] (our unpublished results). This indicates that Mff (like
DLP1) is likely not involved in the constriction of peroxisomes prior to
ﬁssion. More importantly, as an elongated and constricted peroxisome
morphology in patient ﬁbroblasts may be the result of mutations in ei-
ther DLP1 or Mff, both genes should be analyzed for potential muta-
tions. In contrast to Fis, Mff localizes in spots on mitochondria (and
peroxisomes; our unpublished results) (Fig. 3), and overexpression of
Mff promotes the recruitment of DLP1 tomitochondria, and thus, mito-
chondrial division [151]. In summary, these ﬁndings strongly support a
major role for Mff in recruiting DLP1 to mitochondria and peroxisomes.
If Mff is indeed the essential DLP1 receptor in mammals, what is
the function of Fis1 on both organelles? On peroxisomes, Fis1 is sup-
posed to interact with Pex11α and Pex11β [103,169] (Table 1), and is
found to co-localize with Pex11β in tubular membrane domains
which are formed prior to peroxisome division [128]. Physical inter-
actions among all ﬁve At-Pex11 proteins and Fis1b have also been
reported in Arabidopsis [123] (Table 1). Thus, Fis1 might function in
the recruitment, assembly and/or regulation of the Mff-DLP1 ﬁssion
machinery after activation of Pex11p (Fig. 2). Interestingly, Fis1 is
also supposed to self-assemble and might play a role in membrane
1353M. Schrader et al. / Biochimica et Biophysica Acta 1822 (2012) 1343–1357constriction [189]. Its cytosolic domain was recently proposed to
drive the association of two opposing bilayers prior to ﬁssion [195].
However, additional functions in apoptosis and autophagy have also
been suggested [196,197].
Finally, MiD49 and MiD51/MIEF1, two novel N-terminally an-
chored mitochondrial membrane proteins, have been found to recruit
DLP1 to mitochondria [198,199]) (Table 2). Like Mff, MiD proteins are
not found in yeast, and present novel components of the mammalian
mitochondrial ﬁssion machinery. In contrast to the Mff-DLP1 complex
that promotes mitochondrial (and peroxisomal) ﬁssion, the MiD pro-
teins have been suggested to sequester DLP1, thus inhibiting DLP1
function, and to promote mitochondrial fusion [200] (Fig. 2). Interest-
ingly, in a mutually exclusive manner, MiD51 binds either to DLP1 or
to Fis1. By that, Fis1 can potentially regulate the inhibitory effect of
MiD51 on DLP1 function and mitochondrial ﬁssion. This scenario
might as well explain some of the apparently contradictory results
reported for the role of Fis1. However,MiD51 andMiD49 do not localize
to peroxisomes (M. Ryan, LaTrobe University, Melbourne, personal
communication, and our own unpublished results) and likely represent
speciﬁc components of themitochondrialﬁssionmachinery. This leaves
us with the current opinion, that Fis1 is a major receptor for DLPs on
mitochondria and peroxisomes in yeast and possibly plants (in cooper-
ation with the adaptor proteins Mdv1 and Caf4), whereas Mff is the
essential DLP1 recruitment factor in mammals (or metazoans), where
Fis1 might fulﬁl a regulatory function (Figs. 2, 3).
5. Conclusions and future perspectives
The investigation of “peroxisomal dynamics” (i. e. addressing per-
oxisome morphology changes, peroxisome morphology proteins,
membrane elongation and remodeling processes, peroxisome divi-
sion and membrane ﬁssion, modes of peroxisome formation and mat-
uration, regulation of peroxisome number, motility and distribution)
has become an exciting new ﬁeld in cell biology and biomedical
sciences because of its potential relation to organelle functionality
and its impact on, developmental and physiological processes
[6,7,9,159,201].
At the organelle level, the key molecular machinery controlling
peroxisomal morphology, dynamics and number is becoming more
and more established and deﬁned (Figs. 2, 3) (Tables 1, 2). It is likely
that in the coming years many more proteins involved in peroxisome
dynamics and morphology will be identiﬁed contributing to a better
understanding of these complex mechanisms. However, information
on the role of membrane lipids in peroxisome dynamics is scarce re-
quiring further investigation. The expression and/or activation of
Pex11 proteins (see Section 3) (Table 1) appears to be a common, ini-
tial event in yeasts, plants and mammals during peroxisome prolifer-
ation (Fig. 3). Some Pex11 proteins function as membrane-shaping
proteins, and directly elongate the peroxisomal membrane prior to
ﬁssion (see Sections 3.2 and 3.3). This activity depends on amphipha-
tic properties found in the N-terminal part of many Pex11 proteins.
Pex11 proteins may as well support the recruitment and/or assembly
of the ﬁssion machinery, which is composed of dynamin-like GTPases
and organism-speciﬁc receptors (and adaptors) at the peroxisomal
membrane (see Section 4) (Table 2). Remarkably, the key ﬁssion
components are shared with mitochondria which is a common strat-
egy used by mammals, fungi and plants (Table 2). There is emerging
evidence that peroxisomes and mitochondria have a much closer in-
terrelationship than previously assumed, which is supposed to have
an impact on their cooperative functionality and contribution to dis-
eases [158–160] (see Section 4).
While several key proteins involved in peroxisome dynamics and
proliferation have been identiﬁed, their coordinated interplay and
the regulation of these processes are not well understood. Post-
translational modiﬁcations are likely to be involved in the regulation
of peroxisome morphology proteins (e.g. Pex11p, DLP1); however,the signaling mechanisms acting upstream of Pex11p differ in mam-
mals, plants and fungi (Fig. 1), and the cellular signals and the precise
modulation of signal transduction pathways by physiological stimuli
leading to peroxisome proliferation are, despite a few exceptions,
largely unexplored, and require further investigation (see Section 2).
Although the ﬁeld is young, there is emerging evidence that per-
oxisomal dynamics and proper regulation of peroxisome number
and morphology are crucial for the physiology of the cell, as well as
for the pathology of the organism and potentially, for host defence.
Dysfunctions of peroxisome-shaping proteins can contribute to de-
velopmental disorders with characteristic peroxisome morphologies
(see Sections 4.2 and 4.3) which can serve as valuable diagnostic in-
dicators. Furthermore, alterations in peroxisome metabolism and
proliferation are often associated with liver diseases or neurodegen-
erative disorders and have been linked to pathological conditions as-
sociated with oxidative stress and to cellular ageing [202,203]. In a
very recent study, peroxisome proliferation and subsequent alter-
ations in ROS levels have been demonstrated to set melanocortin
tone and feeding in diet-induced obesity [45]. These ﬁndings further
highlight the importance of peroxisome proliferation and regulation
of peroxisome number in disease conditions. Understanding how per-
oxisomes manage to divide and proliferate, both on the organelle
level and at the regulatory, signal transduction level will certainly
contribute to therapeutic approaches for the treatment of patients
with defects in peroxisome biogenesis and other disorders.Acknowledgements
We would like to thank members of the laboratory for stimulating
discussions and comments on the manuscript and we apologize to
those whose work has not been cited owing to space limitations.
This work was supported by the Portuguese Foundation for Science
and Technology (FCT) and FEDER (PTDC/SAU-OSM/103647/2008;
PTDC/BIA-BCM/099613/2008; SFRH/BPD/74428/2010 to M. I.; SFRH/
BD/37647/2007 to N. A. B.), CRUP/DAAD (ACÇÕES INTEGRADAS –
2010) and the University of Aveiro.References
[1] R.J.A. Wanders, H.R. Waterham, Biochemistry of mammalian peroxisomes revis-
ited, Annu. Rev. Biochem. 75 (2006) 295–332.
[2] E. Dixit, S. Boulant, Y. Zhang, A.S. Lee, C. Odendall, B. Shum, N. Hacohen, Z.J. Chen,
S.P. Whelan, M. Fransen, M.L. Nibert, G. Superti-Furga, J.C. Kagan, Peroxisomes
are signaling platforms for antiviral innate immunity, Cell 141 (2010) 668–681.
[3] A. Fagarasanu, F.D. Mast, B. Knoblach, R.A. Rachubinski, Molecular mechanisms
of organelle inheritance: lessons from peroxisomes in yeast, Nat. Rev. Mol. Cell
Biol. 11 (2010) 644–654.
[4] M. Oku, Y. Sakai, Peroxisomes as dynamic organelles: autophagic degradation,
FEBS J. 277 (2010) 3289–3294.
[5] P.B. Lazarow, Y. Fujiki, Biogenesis of peroxisomes, Annu. Rev. Cell Biol. 1 (1985)
489–530.
[6] M. Schrader, H.D. Fahimi, Growth and division of peroxisomes, Int. Rev. Cytol.
255 (2006) 237–290.
[7] E.H. Hettema, A.M. Motley, How peroxisomes multiply, J. Cell Sci. 122 (2009)
2331–2336.
[8] D. Hoepfner, D. Schildknegt, I. Braakman, P. Philippsen, H.F. Tabak, Contribution
of the endoplasmic reticulum to peroxisome formation, Cell 122 (2005) 85–95.
[9] S. Nagotu, M. Veenhuis, I.J. van der Klei, Divide et impera: the dictum of perox-
isomes, Trafﬁc 11 (2010) 175–184.
[10] P.K. Kim, R.T. Mullen, U. Schumann, J. Lippincott-Schwartz, The origin and main-
tenance of mammalian peroxisomes involves a de novo PEX16-dependent path-
way from the ER, J. Cell Biol. 173 (2006) 521–532.
[11] A. van der Zand, I. Braakman, H.F. Tabak, Peroxisomal membrane proteins insert
into the endoplasmic reticulum, Mol. Biol. Cell 21 (2010) 2057–2065.
[12] G. Agrawal, S. Joshi, S. Subramani, Cell-free sorting of peroxisomal membrane
proteins from the endoplasmic reticulum, Proc. Natl. Acad. Sci. U. S. A. 108 (2011)
9113–9118.
[13] S.K. Lam, N. Yoda, R. Schekman, A vesicle carrier that mediates peroxisome
protein trafﬁc from the endoplasmic reticulum, Proc. Natl. Acad. Sci. U. S. A.
108 (2011) E51–E52.
[14] R. Hess, W. Staubli, W. Riess, Nature of the hepatomegalic effect produced by
ethyl-chlorophenoxy-isobutyrate in the rat, Nature 208 (1965) 856–858.
1354 M. Schrader et al. / Biochimica et Biophysica Acta 1822 (2012) 1343–1357[15] P.B. Lazarow, C. De Duve, A fatty acyl-CoA oxidizing system in rat liver peroxi-
somes; enhancement by cloﬁbrate, a hypolipidemic drug, Proc. Natl. Acad. Sci.
U. S. A. 73 (1976) 2043–2046.
[16] J.K. Reddy, S. Rao, D.E. Moody, Hepatocellular carcinomas in acatalasemic mice
treated with nafenopin, a hypolipidemic peroxisome proliferator, Cancer Res.
36 (1976) 1211–1217.
[17] M. Islinger, M.J. Cardoso, M. Schrader, Be different—the diversity of peroxisomes
in the animal kingdom, Biochim. Biophys. Acta 1803 (2010) 881–897.
[18] D.E. Moody, J.K. Reddy, B.G. Lake, J.A. Popp, D.H. Reese, Peroxisome proliferation
and nongenotoxic carcinogenesis: commentary on a symposium, Fundam. Appl.
Toxicol. 16 (1991) 233–248.
[19] J.K. Reddy, D.L. Azarnoff, C.E. Hignite, Hypolipidaemic hepatic peroxisome prolif-
erators form a novel class of chemical carcinogens, Nature 283 (1980) 397–398.
[20] J.K. Reddy, J.R. Warren, M.K. Reddy, N.D. Lalwani, Hepatic and renal effects of
peroxisome proliferators: biological implications, Ann. N. Y. Acad. Sci. 386
(1982) 81–110.
[21] P. Gariot, E. Barrat, L.Mejean, J.P. Pointel, P. Drouin,G. Debry, Fenoﬁbrate andhuman
liver. Lack of proliferation of peroxisomes, Arch. Toxicol. 53 (1983) 151–163.
[22] I. Issemann, S. Green, Activation of a member of the steroid hormone receptor
superfamily by peroxisome proliferators, Nature 347 (1990) 645–650.
[23] S.R. Pyper, N. Viswakarma, S. Yu, J.K. Reddy, PPARalpha: energy combustion,
hypolipidemia, inﬂammation and cancer, Nucl. Recept. Signal. 8 (2010) e002.
[24] M. Rakhshandehroo, B. Knoch, M. Muller, S. Kersten, Peroxisome
proliferator-activated receptor alpha target genes, PPAR Res. 2010 (2010).
[25] C. Dreyer, H. Keller, A. Mahfoudi, V. Laudet, G. Krey, W. Wahli, Positive regula-
tion of the peroxisomal beta-oxidation pathway by fatty acids through activa-
tion of peroxisome proliferator-activated receptors (PPAR), Biol. Cell 77
(1993) 67–76.
[26] F.J. Gonzalez, Recent update on the PPAR alpha-null mouse, Biochimie 79 (1997)
139–144.
[27] S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez--
Salguero, H. Westphal, F.J. Gonzalez, Targeted disruption of the alpha isoform
of the peroxisome proliferator-activated receptor gene in mice results in
abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell.
Biol. 15 (1995) 3012–3022.
[28] X. Li, E. Baumgart, G.X. Dong, J.C. Morrell, G. Jimenez-Sanchez, D. Valle, K.D.
Smith, S.J. Gould, PEX11alpha is required for peroxisome proliferation in re-
sponse to 4-phenylbutyrate but is dispensable for peroxisome
proliferator-activated receptor alpha-mediated peroxisome proliferation, Mol.
Cell. Biol. 22 (2002) 8226–8240.
[29] K. Schoonjans, B. Staels, J. Auwerx, Role of the peroxisome proliferator-activated
receptor (PPAR) in mediating the effects of ﬁbrates and fatty acids on gene
expression, J. Lipid Res. 37 (1996) 907–925.
[30] S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, R.M. Evans, Convergence
of 9-cis retinoic acid and peroxisome proliferator signalling pathways through
heterodimer formation of their receptors, Nature 358 (1992) 771–774.
[31] C. Wolfrum, C.M. Borrmann, T. Borchers, F. Spener, Fatty acids and hypolipi-
demic drugs regulate peroxisome proliferator-activated receptors alpha- and
gamma-mediated gene expression via liver fatty acid binding protein: a signal-
ing path to the nucleus, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2323–2328.
[32] M.T. Bility, J.T. Thompson, R.H. McKee, R.M. David, J.H. Butala, J.P. Vanden Heuvel,
J.M. Peters, Activation of mouse and human peroxisome proliferator-activated re-
ceptors (PPARs) by phthalate monoesters, Toxicol. Sci. 82 (2004) 170–182.
[33] T.M. Willson, P.J. Brown, D.D. Sternbach, B.R. Henke, The PPARs: from orphan re-
ceptors to drug discovery, J. Med. Chem. 43 (2000) 527–550.
[34] S. Yu, W.Q. Cao, P. Kashireddy, K. Meyer, Y. Jia, D.E. Hughes, Y. Tan, J. Feng, A.V.
Yeldandi, M.S. Rao, R.H. Costa, F.J. Gonzalez, J.K. Reddy, Human peroxisome
proliferator-activated receptor alpha (PPARalpha) supports the induction of
peroxisome proliferation in PPARalpha-deﬁcient mouse liver, J. Biol. Chem.
276 (2001) 42485–42491.
[35] C.N. Palmer, M.H. Hsu, K.J. Grifﬁn, J.L. Raucy, E.F. Johnson, Peroxisome prolifera-
tor activated receptor-alpha expression in human liver, Mol. Pharmacol. 53
(1998) 14–22.
[36] J.D. Tugwood, P.R. Holden, N.H. James, R.A. Prince, R.A. Roberts, A peroxisome
proliferator-activated receptor-alpha (PPARalpha) cDNA cloned from
guinea-pig liver encodes a protein with similar properties to the mouse PPARal-
pha: implications for species differences in responses to peroxisome prolifera-
tors, Arch. Toxicol. 72 (1998) 169–177.
[37] C.D. Kane, O.L. Francone, K.A. Stevens, Differential regulation of the cynomolgus,
human, and rat acyl-CoA oxidase promoters by PPARalpha, Gene 380 (2006)
84–94.
[38] Q. Yang, T. Nagano, Y. Shah, C. Cheung, S. Ito, F.J. Gonzalez, The PPAR
alpha-humanized mouse: a model to investigate species differences in liver tox-
icity mediated by PPAR alpha, Toxicol. Sci. 101 (2008) 132–139.
[39] Z. El Kebbaj, P. Andreoletti, D. Mountassif, M. Kabine, H. Schohn, M. Dauca, N.
Latruffe, M.S. El Kebbaj, M. Cherkaoui-Malki, Differential regulation of peroxisome
proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an
adaptive response to fasting in the control of hepatic peroxisomal fatty acid
beta-oxidation in the hibernatingmammal, Endocrinology 150 (2009) 1192–1201.
[40] H.M. Guardiola-Diaz, S. Rehnmark, N. Usuda, T. Albrektsen, D. Feltkamp, J.A.
Gustafsson, S.E. Alexson, Rat peroxisome proliferator-activated receptors and
brown adipose tissue function during cold acclimatization, J. Biol. Chem. 274
(1999) 23368–23377.
[41] M. Kabine, M.C. Clemencet, J. Bride, M.S. El Kebbaj, N. Latruffe, M. Cherkaoui--
Malki, Changes of peroxisomal fatty acid metabolism during cold acclimatiza-
tion in hibernating jerboa (Jaculus orientalis), Biochimie 85 (2003) 707–714.[42] A. Bagattin, L. Hugendubler, E. Mueller, Transcriptional coactivator PGC-1alpha
promotes peroxisomal remodeling and biogenesis, Proc. Natl. Acad. Sci. U. S. A.
107 (2010) 20376–20381.
[43] C. Handschin, The biology of PGC-1alpha and its therapeutic potential, Trends
Pharmacol. Sci. 30 (2009) 322–329.
[44] K.L. DeCicco, T. Tanaka, F. Andreola, L.M. De Luca, The effect of thalidomide on
non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPAR-
gamma pathway, Carcinogenesis 25 (2004) 1805–1812.
[45] S. Diano, Z.W. Liu, J.K. Jeong, M.O. Dietrich, H.B. Ruan, E. Kim, S. Suyama, K. Kelly,
E. Gyengesi, J.L. Arbiser, D.D. Belsham, D.A. Sarruf, M.W. Schwartz, A.M. Bennett,
M. Shanabrough, C.V. Mobbs, X. Yang, X.B. Gao, T.L. Horvath, Peroxisome
proliferation-associated control of reactive oxygen species sets melanocortin
tone and feeding in diet-induced obesity, Nat. Med. 17 (2011) 1121–1127.
[46] E. Baumgart, A. Volkl, J. Pill, H.D. Fahimi, Proliferation of peroxisomes without si-
multaneous induction of the peroxisomal fatty acid beta-oxidation, FEBS Lett.
264 (1990) 5–9.
[47] C. Gondcaille,M. Depreter, S. Fourcade, M.R. Lecca, S. Leclercq, P.G. Martin, T. Pineau,
F. Cadepond, M. ElEtr, N. Bertrand, A. Beley, S. Duclos, D. De Craemer, F. Roels, S.
Savary, M. Bugaut, Phenylbutyrate up-regulates the adrenoleukodystrophy-related
gene as a nonclassical peroxisome proliferator, J. Cell Biol. 169 (2005) 93–104.
[48] M. Schrader, K. Krieglstein, H.D. Fahimi, Tubular peroxisomes in HepG2 cells:
selective induction by growth factors and arachidonic acid, Eur. J. Cell Biol. 75
(1998) 87–96.
[49] M. Schrader, B.E. Reuber, J.C. Morrell, G. Jimenez-Sanchez, C. Obie, T.A. Stroh, D.
Valle, T.A. Schroer, S.J. Gould, Expression of PEX11beta mediates peroxisome
proliferation in the absence of extracellular stimuli, J. Biol. Chem. 273 (1998)
29607–29614.
[50] T. Braunbeck, S. Appelbaum, Ultrastructural alterations in the liver and intestine
of carp Cyprinus carpio induced orally by ultra-low doses of endosulfan, Dis.
Aquat. Organ. 36 (1999) 183–200.
[51] P. Abraham, B. Isaac, Ultrastructural changes in the rat kidney after single dose
of cyclophosphamide—possible roles for peroxisome proliferation and lysosom-
al dysfunction in cyclophosphamide induced renal damage, Hum. Exp. Toxicol.
30 (12) (2011) 1924–1930.
[52] M. Ortiz-Zarragoitia, M.P. Cajaraville, Effects of selected xenoestrogens on liver
peroxisomes, vitellogenin levels and spermatogenic cell proliferation in male
zebraﬁsh, Comp. Biochem. Physiol. C Toxicol. Pharmacol. 141 (2005) 133–144.
[53] Y. Cai, A.K. Sohlenius, K. Andersson, C. Sundberg, J.W. DePierre, Effects of acetyl-
salicylic acid on parameters related to peroxisome proliferation in mouse liver,
Biochem. Pharmacol. 47 (1994) 2213–2219.
[54] T. Braunbeck, A. Volkl, Induction of biotransformation in the liver of Eel (Anguil-
la anguilla L.) by sublethal exposure to dinitro-o-cresol: an ultrastructural and
biochemical study, Ecotoxicol. Environ. Saf. 21 (1991) 109–127.
[55] H. Keller, F. Givel, M. Perroud, W. Wahli, Signaling cross-talk between
peroxisome proliferator-activated receptor/retinoid X receptor and estrogen
receptor through estrogen response elements, Mol. Endocrinol. 9 (1995)
794–804.
[56] S.B. Nunez, J.A. Medin, O. Braissant, L. Kemp, W. Wahli, K. Ozato, J.H. Segars, Ret-
inoid X receptor and peroxisome proliferator-activated receptor activate an es-
trogen responsive gene independent of the estrogen receptor, Mol. Cell.
Endocrinol. 127 (1997) 27–40.
[57] M.L. Circu, T.Y. Aw, Reactive oxygen species, cellular redox systems, and apopto-
sis, Free Radic. Biol. Med. 48 (2010) 749–762.
[58] W.S. Wu, The signaling mechanism of ROS in tumor progression, Cancer Metas-
tasis Rev. 25 (2006) 695–705.
[59] N.A. Bonekamp, A. Volkl, H.D. Fahimi, M. Schrader, Reactive oxygen species and
peroxisomes: struggling for balance, Biofactors 35 (2009) 346–355.
[60] M. Schrader, H.D. Fahimi, Peroxisomes and oxidative stress, Biochim. Biophys.
Acta 1763 (2006) 1755–1766.
[61] D. De Craemer, M. Pauwels, C. Van den Branden, Alterations of peroxisomes in
steatosis of the human liver: a quantitative study, Hepatology 22 (1995)
744–752.
[62] J.A. Litwin, K. Beier, A. Volkl, W.J. Hofmann, H.D. Fahimi, Immunocytochemical
investigation of catalase and peroxisomal lipid beta-oxidation enzymes in
human hepatocellular tumors and liver cirrhosis, Virchows Arch. 435 (1999)
486–495.
[63] T. Hashimoto, W.S. Cook, C. Qi, A.V. Yeldandi, J.K. Reddy, M.S. Rao, Defect in
peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation
determines the severity of hepatic steatosis in response to fasting, J. Biol.
Chem. 275 (2000) 28918–28928.
[64] M. Fischer, M. You, M. Matsumoto, D.W. Crabb, Peroxisome
proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses
PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in
ethanol-fed mice, J. Biol. Chem. 278 (2003) 27997–28004.
[65] E. Ip, G. Farrell, P. Hall, G. Robertson, I. Leclercq, Administration of the potent
PPARalpha agonist, Wy-14,643, reverses nutritional ﬁbrosis and steatohepatitis
in mice, Hepatology 39 (2004) 1286–1296.
[66] A.A. Nanji, A.J. Dannenberg, K. Jokelainen, N.M. Bass, Alcoholic liver injury in the
rat is associated with reduced expression of peroxisome proliferator-alpha
(PPARalpha)-regulated genes and is ameliorated by PPARalpha activation, J.
Pharmacol. Exp. Ther. 310 (2004) 417–424.
[67] Y.J. Wan, M. Morimoto, R.G. Thurman, H.K. Bojes, S.W. French, Expression of the
peroxisome proliferator-activated receptor gene is decreased in experimental
alcoholic liver disease, Life Sci. 56 (1995) 307–317.
[68] E. Albano, Oxidative mechanisms in the pathogenesis of alcoholic liver disease,
Mol. Aspects Med. 29 (2008) 9–16.
1355M. Schrader et al. / Biochimica et Biophysica Acta 1822 (2012) 1343–1357[69] G.H. Koek, P.R. Liedorp, A. Bast, The role of oxidative stress in non-alcoholic
steatohepatitis, Clin. Chim. Acta 412 (2011) 1297–1305.
[70] M.G. Sanal, The blind men ‘see’ the elephant—the many faces of fatty liver
disease, World J. Gastroenterol. 14 (2008) 831–844.
[71] D. De Craemer, A. Bingen, M. Langendries, J.P. Martin, F. Roels, Alterations of
hepatocellular peroxisomes in viral hepatitis in the mouse, J. Hepatol. 11
(1990) 145–152.
[72] D. De Craemer, M. Pauwels, M. Hautekeete, F. Roels, Alterations of hepatocellular
peroxisomes in patients with cancer. Catalase cytochemistry and morphometry,
Cancer 71 (1993) 3851–3858.
[73] C. Loguercio, A. Federico, Oxidative stress in viral and alcoholic hepatitis, Free
Radic. Biol. Med. 34 (2003) 1–10.
[74] M. Persico, A. Iolascon, Steatosis as a co-factor in chronic liver diseases, World J.
Gastroenterol. 16 (2010) 1171–1176.
[75] P.E. Purdue, P.B. Lazarow, Peroxisome biogenesis, Annu. Rev. Cell Dev. Biol. 17
(2001) 701–752.
[76] R. Erdmann, G. Blobel, Giant peroxisomes in oleic acid-induced Saccharomyces
cerevisiae lacking the peroxisomal membrane protein Pmp27p, J. Cell Biol. 128
(1995) 509–523.
[77] P.A. Marshall, Y.I. Krimkevich, R.H. Lark, J.M. Dyer, M. Veenhuis, J.M. Goodman,
Pmp27 promotes peroxisomal proliferation, J. Cell Biol. 129 (1995) 345–355.
[78] A. Gurvitz, H. Rottensteiner, The biochemistry of oleate induction: transcription-
al upregulation and peroxisome proliferation, Biochim. Biophys. Acta 1763
(2006) 1392–1402.
[79] C. Phelps, V. Gburcik, E. Suslova, P. Dudek, F. Forafonov, N. Bot, M. MacLean, R.J.
Fagan, D. Picard, Fungi and animals may share a common ancestor to nuclear
receptors, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7077–7081.
[80] A.Gurvitz, J.K. Hiltunen, R. Erdmann, B.Hamilton,A.Hartig, H. Ruis, H. Rottensteiner,
Saccharomyces cerevisiae Adr1p governs fatty acid beta-oxidation and peroxi-
some proliferation by regulating POX1 and PEX11, J. Biol. Chem. 276 (2001)
31825–31830.
[81] I.V. Karpichev, J.M. Durand-Heredia, Y. Luo, G.M. Small, Binding characteristics
and regulatory mechanisms of the transcription factors controlling
oleate-responsive genes in Saccharomyces cerevisiae, J. Biol. Chem. 283 (2008)
10264–10275.
[82] G.P. Lin-Cereghino, L. Godfrey, B.J. de la Cruz, S. Johnson, S. Khuongsathiene, I.
Tolstorukov, M. Yan, J. Lin-Cereghino, M. Veenhuis, S. Subramani, J.M. Cregg,
Mxr1p, a key regulator of the methanol utilization pathway and peroxisomal
genes in Pichia pastoris, Mol. Cell. Biol. 26 (2006) 883–897.
[83] M. Simon, M. Binder, G. Adam, A. Hartig, H. Ruis, Control of peroxisome prolifer-
ation in Saccharomyces cerevisiae by ADR1, SNF1 (CAT1, CCR1) and SNF4
(CAT3), Yeast 8 (1992) 303–309.
[84] S. Ratnakumar, N. Kacherovsky, E. Arms, E.T. Young, Snf1 controls the activity of
adr1 through dephosphorylation of Ser230, Genetics 182 (2009) 735–745.
[85] S. Ratnakumar, E.T. Young, Snf1 dependence of peroxisomal gene expression is
mediated by Adr1, J. Biol. Chem. 285 (2010) 10703–10714.
[86] D.G. Hardie, D. Carling, M. Carlson, The AMP-activated/SNF1 protein kinase sub-
family: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 67 (1998)
821–855.
[87] M.J. Hynes, S.L. Murray, A. Duncan, G.S. Khew, M.A. Davis, Regulatory genes con-
trolling fatty acid catabolism and peroxisomal functions in the ﬁlamentous fun-
gus Aspergillus nidulans, Eukaryot. Cell 5 (2006) 794–805.
[88] M.J. Hynes, S.L. Murray, G.S. Khew, M.A. Davis, Genetic analysis of the role of per-
oxisomes in the utilization of acetate and fatty acids in Aspergillus nidulans, Ge-
netics 178 (2008) 1355–1369.
[89] K. Reiser, M.A. Davis, M.J. Hynes, AoxA is a major peroxisomal long chain fatty
acyl-CoA oxidase required for beta-oxidation in A. nidulans, Curr. Genet. 56
(2010) 139–150.
[90] K. Reiser, M.A. Davis, M.J. Hynes, Aspergillus nidulans contains six possible fatty
acyl-CoA synthetases with FaaB being the major synthetase for fatty acid degra-
dation, Arch. Microbiol. 192 (2010) 373–382.
[91] N. Poopanitpan, S. Kobayashi, R. Fukuda, H. Horiuchi, A. Ohta, An ortholog of farA
of Aspergillus nidulans is implicated in the transcriptional activation of genes in-
volved in fatty acid utilization in the yeast Yarrowia lipolytica, Biochem. Bio-
phys. Res. Commun. 402 (2010) 731–735.
[92] E. Lopez-Huertas, W.L. Charlton, B. Johnson, I.A. Graham, A. Baker, Stress induces
peroxisome biogenesis genes, EMBO J. 19 (2000) 6770–6777.
[93] S. Mitsuya, M. El-Shami, I.A. Sparkes, W.L. Charlton, M. Lousa Cde, B. Johnson, A.
Baker, Salt stress causes peroxisome proliferation, but inducing peroxisome pro-
liferation does not improve NaCl tolerance in Arabidopsis thaliana, PLoS One 5
(2010) e9408.
[94] J.M. Palma, M. Garrido, M.I. Rodriguez-Garcia, L.A. del Rio, Peroxisome prolifera-
tion and oxidative stress mediated by activated oxygen species in plant peroxi-
somes, Arch. Biochem. Biophys. 287 (1991) 68–74.
[95] A.M. Sinclair, C.P. Trobacher, N. Mathur, J.S. Greenwood, J. Mathur, Peroxule ex-
tension over ER deﬁned paths constitutes a rapid subcellular response to hy-
droxyl stress, Plant J. 59 (2) (2009) 231–242.
[96] M.C. Castillo, L.M. Sandalio, L.A. Del Rio, J. Leon, Peroxisome proliferation,
wound-activated responses and expression of peroxisome-associated genes
are cross-regulated but uncoupled in Arabidopsis thaliana, Plant Cell Environ.
31 (2008) 492–505.
[97] L.J. Olsen, W.F. Ettinger, B. Damsz, K. Matsudaira, M.A. Webb, J.J. Harada, Target-
ing of glyoxysomal proteins to peroxisomes in leaves and roots of a higher plant,
Plant Cell 5 (1993) 941–952.
[98] M. Desai, J. Hu, Light induces peroxisome proliferation in Arabidopsis seedlings
through the photoreceptor phytochrome A, the transcription factor HY5HOMOLOG, and the peroxisomal protein PEROXIN11b, Plant Physiol. 146
(2008) 1117–1127.
[99] J. Hu, Molecular basis of peroxisome division and proliferation in plants, Int. Rev.
Cell Mol. Biol. 279 (2010) 79–99.
[100] H. Wang, X.W. Deng, Dissecting the phytochrome A-dependent signaling net-
work in higher plants, Trends Plant Sci. 8 (2003) 172–178.
[101] I. Abe, Y. Fujiki, cDNA cloning and characterization of a constitutively expressed
isoform of the human peroxin Pex11p, Biochem. Biophys. Res. Commun. 252
(1998) 529–533.
[102] I. Abe, K. Okumoto, S. Tamura, Y. Fujiki, Cloﬁbrate-inducible, 28-kDa peroxisomal
integral membrane protein is encoded by PEX11, FEBS Lett. 431 (1998) 468–472.
[103] J. Koch, K. Pranjic, A. Huber, A. Ellinger, A. Hartig, F. Kragler, C. Brocard, PEX11
family members are membrane elongation factors that coordinate peroxisome
proliferation and maintenance, J. Cell Sci. 123 (2010) 3389–3400.
[104] J.M. Goodman, J. Maher, P.A. Silver, A. Paciﬁco, D. Sanders, The membrane pro-
teins of the methanol-induced peroxisome of Candida boidinii. Initial character-
ization and generation of monoclonal antibodies, J. Biol. Chem. 261 (1986)
3464–3468.
[105] M. Moreno, R. Lark, K.L. Campbell, J.M. Goodman, The peroxisomal membrane
proteins of Candida boidinii: gene isolation and expression, Yeast 10 (1994)
1447–1457.
[106] H. Rottensteiner, K. Stein, E. Sonnenhol, R. Erdmann, Conserved function of
pex11p and the novel pex25p and pex27p in peroxisome biogenesis, Mol. Biol.
Cell 14 (2003) 4316–4328.
[107] Y.Y. Tam, J.C. Torres-Guzman, F.J. Vizeacoumar, J.J. Smith, M. Marelli, J.D. Aitchison,
R.A. Rachubinski, Pex11-related proteins in peroxisome dynamics: a role for the
novel peroxin Pex27p in controlling peroxisome size and number in Saccharomy-
ces cerevisiae, Mol. Biol. Cell 14 (2003) 4089–4102.
[108] P. Lorenz, A.G. Maier, E. Baumgart, R. Erdmann, C. Clayton, Elongation and clus-
tering of glycosomes in Trypanosoma brucei overexpressing the glycosomal
Pex11p, EMBO J. 17 (1998) 3542–3555.
[109] A. Maier, P. Lorenz, F. Voncken, C. Clayton, An essential dimeric membrane pro-
tein of trypanosome glycosomes, Mol. Microbiol. 39 (2001) 1443–1451.
[110] F. Voncken, J.J. van Hellemond, I. Pﬁsterer, A. Maier, S. Hillmer, C. Clayton, Deple-
tion of GIM5 causes cellular fragility, a decreased glycosome number, and re-
duced levels of ether-linked phospholipids in trypanosomes, J. Biol. Chem. 278
(2003) 35299–35310 (Epub 32003 Jun 35226).
[111] R. Saraya, A.M. Krikken, M. Veenhuis, I.J. van der Klei, Peroxisome reintroduction
in Hansenula polymorpha requires Pex25 and Rho1, J. Cell Biol. 193 (2011)
885–900.
[112] A. Huber, J. Koch, F. Kragler, C. Brocard, A. Hartig, A subtle interplay between
three Pex11 proteins shapes de novo formation and ﬁssion of peroxisomes,
Trafﬁc 13 (1) (2011) 157–167.
[113] J.A. Kiel, M. Veenhuis, I.J. van der Klei, PEX genes in fungal genomes: common,
rare or redundant, Trafﬁc 7 (2006) 1291–1303.
[114] X. Li, E. Baumgart, J.C. Morrell, G. Jimenez-Sanchez, D. Valle, S.J. Gould, PEX11
beta deﬁciency is lethal and impairs neuronal migration but does not abrogate
peroxisome function, Mol. Cell. Biol. 22 (2002) 4358–4365.
[115] M. Passreiter, M. Anton, D. Lay, R. Frank, C. Harter, F.T. Wieland, K. Gorgas, W.W.
Just, Peroxisome biogenesis: involvement of ARF and coatomer, J. Cell Biol. 141
(1998) 373–383.
[116] M. Shimizu, A. Takeshita, T. Tsukamoto, F.J. Gonzalez, T. Osumi, Tissue-selective,
bidirectional regulation of PEX11 alpha and perilipin genes through a common
peroxisome proliferator response element, Mol. Cell. Biol. 24 (2004) 1313–1323.
[117] A. Tanaka, K. Okumoto, Y. Fujiki, cDNA cloning and characterization of the third
isoform of human peroxin Pex11p, Biochem. Biophys. Res. Commun. 300 (2003)
819–823.
[118] C.S. Escano, P.R. Juvvadi, F.J. Jin, T. Takahashi, Y. Koyama, S. Yamashita, J.Maruyama,
K. Kitamoto, Disruption of the Aopex11-1 gene involved in peroxisome prolifera-
tion leads to impaired Woronin body formation in Aspergillus oryzae, Eukaryot.
Cell 8 (2009) 296–305.
[119] M.J. Lingard, R.N. Trelease, Five Arabidopsis peroxin 11 homologs individually
promote peroxisome elongation, division without elongation, or aggregation, J.
Cell Sci. 119 (2006) 1961–1972.
[120] N. Kaur, J. Hu, Dynamics of peroxisome abundance: a tale of division and prolif-
eration, Curr. Opin. Plant Biol. 12 (2009) 781–788.
[121] T. Orth, S. Reumann, X. Zhang, J. Fan, D. Wenzel, S. Quan, J. Hu, The PEROXIN11
protein family controls peroxisome proliferation in Arabidopsis, Plant Cell 19
(2007) 333–350.
[122] P.A. Marshall, J.M. Dyer, M.E. Quick, J.M. Goodman, Redox-sensitive homodimer-
ization of Pex11p: a proposed mechanism to regulate peroxisomal division, J.
Cell Biol. 135 (1996) 123–137.
[123] M.J. Lingard, S.K. Gidda, S. Bingham, S.J. Rothstein, R.T. Mullen, R.N. Trelease,
Arabidopsis PEROXIN11c-e, FISSION1b, and DYNAMIN-RELATED PROTEIN3A co-
operate in cell cycle-associated replication of peroxisomes, Plant Cell 20 (2008)
1567–1585.
[124] A. Fagarasanu, M. Fagarasanu, R.A. Rachubinski, Maintaining peroxisome popu-
lations: a story of division and inheritance, Annu. Rev. Cell Dev. Biol. 23 (2007)
321–344.
[125] S. Thoms, R. Erdmann, Dynamin-related proteins and Pex11 proteins in peroxi-
some division and proliferation, FEBS J. 272 (2005) 5169–5181.
[126] M. Yan, N. Rayapuram, S. Subramani, The control of peroxisome number and size
during division and proliferation, Curr. Opin. Cell Biol. 17 (2005) 376–383.
[127] L. Opalinski, M. Veenhuis, I.J. van der Klei, Peroxisomes: membrane events
accompanying peroxisome proliferation, Int. J. Biochem. Cell Biol. 43 (2011)
847–851.
1356 M. Schrader et al. / Biochimica et Biophysica Acta 1822 (2012) 1343–1357[128] H.K. Delille, B. Agricola, S.C. Guimaraes, H. Borta, G.H. Luers, M. Fransen, M.
Schrader, Pex11pbeta-mediated growth and division of mammalian peroxi-
somes follows a maturation pathway, J. Cell Sci. 123 (2010) 2750–2762.
[129] H.K. Delille, G. Dodt, M. Schrader, Pex11pbeta-mediated maturation of peroxi-
somes, Commun. Integr. Biol. 4 (2011) 51–54.
[130] A.M. Motley, E.H. Hettema, Yeast peroxisomes multiply by growth and division,
J. Cell Biol. 178 (2007) 399–410.
[131] J. Woudenberg, K.P. Rembacz, M. Hoekstra, A. Pellicoro, F.A. van den Heuvel, J.
Heegsma, S.C. van Ijzendoorn, A. Holzinger, T. Imanaka, H. Moshage, K.N.
Faber, Lipid rafts are essential for peroxisome biogenesis in HepG2 cells, Hepa-
tology 52 (2010) 623–633.
[132] S.J. Huybrechts, P.P. Van Veldhoven, C. Brees, G.P. Mannaerts, G.V. Los, M. Fransen,
Peroxisome dynamics in cultured mammalian cells, Trafﬁc 10 (2009) 1722–1733.
[133] J. Koch, C. Brocard, Membrane elongation factors in organelle maintenance: the
case of peroxisome proliferation, Biomol Concepts 2 (2011) 353–364.
[134] W.H. Kunau, Peroxisome biogenesis: end of the debate, Curr. Biol. 15 (2005)
R774–R776.
[135] M.N. Cepinska, M. Veenhuis, I.J. van der Klei, S. Nagotu, Peroxisome ﬁssion is
associated with reorganization of speciﬁc membrane proteins, Trafﬁc 12
(2011) 925–937.
[136] A.M. Krikken, M. Veenhuis, I.J. van der Klei, Hansenula polymorpha pex11 cells
are affected in peroxisome retention, FEBS J. 276 (2009) 1429–1439.
[137] L. Opalinski, J.A. Kiel, C. Williams, M. Veenhuis, I.J. van der Klei, Membrane
curvature during peroxisome ﬁssion requires Pex11, EMBO J. 30 (2011) 5–16.
[138] G. Drin, B. Antonny, Amphipathic helices and membrane curvature, FEBS Lett.
584 (2010) 1840–1847.
[139] B. Knoblach, R.A. Rachubinski, Phosphorylation-dependent activation of peroxi-
some proliferator protein PEX11 controls peroxisome abundance, J. Biol. Chem.
285 (2010) 6670–6680.
[140] F.J. Vizeacoumar, J.C. Torres-Guzman, Y.Y. Tam, J.D. Aitchison, R.A. Rachubinski,
YHR150w and YDR479c encode peroxisomal integral membrane proteins in-
volved in the regulation of peroxisome number, size, and distribution in Saccha-
romyces cerevisiae, J. Cell Biol. 161 (2003) 321–332.
[141] L.A. Brown, A. Baker, Peroxisome biogenesis and the role of protein import, J.
Cell Mol. Med. 7 (2003) 388–400.
[142] F.J. Vizeacoumar, J.C. Torres-Guzman, D. Bouard, J.D. Aitchison, R.A. Rachubinski,
Pex30p, Pex31p, and Pex32p form a family of peroxisomal integral membrane
proteins regulating peroxisome size and number in Saccharomyces cerevisiae,
Mol. Biol. Cell 15 (2004) 665–677.
[143] R.J. Tower, A. Fagarasanu, J.D. Aitchison, R.A. Rachubinski, The peroxin Pex34p
functions with the Pex11 family of peroxisomal divisional proteins to regulate
the peroxisome population in yeast, Mol. Biol. Cell 22 (2011) 1727–1738.
[144] G.J. Praefcke, H.T. McMahon, The dynamin superfamily: universal membrane
tubulation and ﬁssion molecules? Nat. Rev. Mol. Cell Biol. 5 (2004) 133–147.
[145] E. Ingerman, E.M. Perkins, M. Marino, J.A. Mears, J.M. McCaffery, J.E. Hinshaw, J.
Nunnari, Dnm1 forms spirals that are structurally tailored to ﬁt mitochondria, J.
Cell Biol. 170 (2005) 1021–1027.
[146] Y. Yoon, K.R. Pitts, M.A. McNiven, Mammalian dynamin-like protein DLP1 tubu-
lates membranes, Mol. Biol. Cell 12 (2001) 2894–2905.
[147] J.A. Mears, L.L. Lackner, S. Fang, E. Ingerman, J. Nunnari, J.E. Hinshaw, Conforma-
tional changes in Dnm1 support a contractile mechanism for mitochondrial ﬁs-
sion, Nat. Struct. Mol. Biol. 18 (2011) 20–26.
[148] A. Koch, G. Schneider, G.H. Luers, M. Schrader, Peroxisome elongation and con-
striction but not ﬁssion can occur independently of dynamin-like protein 1, J.
Cell Sci. 117 (2004) 3995–4006.
[149] S. Gandre-Babbe, A.M. van der Bliek, The novel tail-anchored membrane protein
Mff controls mitochondrial and peroxisomal ﬁssion in mammalian cells, Mol.
Biol. Cell 19 (2008) 2402–2412.
[150] A. Koch, Y. Yoon, N.A. Bonekamp, M.A. McNiven, M. Schrader, A role for ﬁs1 in
both mitochondrial and peroxisomal ﬁssion in mammalian cells, Mol. Biol. Cell
16 (2005) 5077–5086.
[151] H. Otera, C. Wang, M.M. Cleland, K. Setoguchi, S. Yokota, R.J. Youle, K. Mihara,
Mff is an essential factor for mitochondrial recruitment of Drp1 during mito-
chondrial ﬁssion in mammalian cells, J. Cell Biol. 191 (2010) 1141–1158.
[152] K. Kuravi, S. Nagotu, A.M. Krikken,K. Sjollema,M.Deckers, R. Erdmann,M. Veenhuis,
I.J. van der Klei, Dynamin-related proteins Vps1p and Dnm1p control peroxisome
abundance in Saccharomyces cerevisiae, J. Cell Sci. 119 (2006) 3994–4001.
[153] A.M. Motley, G.P. Ward, E.H. Hettema, Dnm1p-dependent peroxisome ﬁssion
requires Caf4p, Mdv1p and Fis1p, J. Cell Sci. 121 (2008) 1633–1640.
[154] D. Hoepfner, M. van den Berg, P. Philippsen, H.F. Tabak, E.H. Hettema, A role for
Vps1p, actin, and the Myo2p motor in peroxisome abundance and inheritance in
Saccharomyces cerevisiae, J. Cell Biol. 155 (2001) 979–990.
[155] F.J. Vizeacoumar, W.N. Vreden, G.A. Eitzen, J.D. Aitchison, R.A. Rachubinski, The
dynamin-like protein Vps1p of the yeast Saccharomyces cerevisiae associates with
peroxisomes in a Pex19p-dependentmanner, J. Biol. Chem. 281 (2006) 12817–12823.
[156] R. Pan, J. Hu, The conserved ﬁssion complex on peroxisomes and mitochondria,
Plant Signal. Behav. 6 (2011) 870–872.
[157] K. Aung, J. Hu, The Arabidopsis Tail-anchored protein PEROXISOMAL ANDMITO-
CHONDRIAL DIVISION FACTOR1 is involved in the morphogenesis and prolifer-
ation of peroxisomes and mitochondria, Plant Cell (2011) Dec. 9 Epub ahead
of print doi:org/10.1105/tpc.111.090142.
[158] H.K. Delille, R. Alves, M. Schrader, Biogenesis of peroxisomes and mitochondria:
linked by division, Histochem. Cell Biol. 131 (2009) 441–446.
[159] F. Camoes, N.A. Bonekamp, H.K. Delille, M. Schrader, Organelle dynamics and
dysfunction: a closer link between peroxisomes and mitochondria, J. Inherit.
Metab. Dis. 32 (2009) 163–180.[160] M. Schrader, Y. Yoon, Mitochondria and peroxisomes: are the ‘Big Brother’ and
the ‘Little Sister’ closer than assumed? Bioessays 29 (2007) 1105–1114.
[161] O. Ivashchenko, P.P. Van Veldhoven, C. Brees, Y.S. Ho, S.R. Terlecky, M. Fransen,
Intraperoxisomal redox balance in mammalian cells: oxidative stress and inter-
organellar cross-talk, Mol. Biol. Cell 22 (2011) 1440–1451.
[162] M. Neuspiel, A.C. Schauss, E. Braschi, R. Zunino, P. Rippstein, R.A. Rachubinski,
M.A. Andrade-Navarro, H.M. McBride, Cargo-selected transport from the mito-
chondria to peroxisomes is mediated by vesicular carriers, Curr. Biol. 18
(2008) 102–108.
[163] S. Hoppins, L. Lackner, J. Nunnari, The machines that divide and fuse mitochon-
dria, Annu. Rev. Biochem. 76 (2007) 751–780.
[164] K. Okamoto, J.M. Shaw, Mitochondrial morphology and dynamics in yeast and
multicellular eukaryotes, Annu. Rev. Genet. 39 (2005) 503–536.
[165] B. Westermann, Mitochondrial fusion and ﬁssion in cell life and death, Nat. Rev.
Mol. Cell Biol. 11 (2010) 872–884.
[166] N.A. Bonekamp, P. Sampaio, G.H. Luers, M. Schrader, Peroxisomal dynamics: do
mammalian peroxisomes fuse with each other? Open European Peroxisome
Meeting 2010, Lunteren, The Netherlands, 2010.
[167] V.I. Titorenko, R.A. Rachubinski, Dynamics of peroxisome assembly and function,
Trends Cell Biol. 11 (2001) 22–29.
[168] M. Schrader, S.J. King, T.A. Stroh, T.A. Schroer, Real time imaging reveals a perox-
isomal reticulum in living cells, J. Cell Sci. 113 (2000) 3663–3671.
[169] S. Kobayashi, A. Tanaka, Y. Fujiki, Fis1, DLP1, and Pex11p coordinately regulate
peroxisome morphogenesis, Exp. Cell Res. 313 (2007) 1675–1686.
[170] A. Koch, M. Thiemann, M. Grabenbauer, Y. Yoon, M.A. McNiven, M. Schrader,
Dynamin-like protein 1 is involved in peroxisomal ﬁssion, J. Biol. Chem. 278
(2003) 8597–8605.
[171] X. Li, S.J. Gould, The dynamin-like GTPase DLP1 is essential for peroxisome divi-
sion and is recruited to peroxisomes in part by PEX11, J. Biol. Chem. 278 (2003)
17012–17020.
[172] M. Schrader, J.K. Burkhardt, E. Baumgart, G. Luers, H. Spring, A. Volkl, H.D.
Fahimi, Interaction of microtubules with peroxisomes. Tubular and spherical
peroxisomes in HepG2 cells and their alterations induced by
microtubule-active drugs, Eur. J. Cell Biol. 69 (1996) 24–35.
[173] H.R. Waterham, J. Koster, C.W. van Roermund, P.A. Mooyer, R.J. Wanders, J.V.
Leonard, A lethal defect of mitochondrial and peroxisomal ﬁssion, N. Engl. J.
Med. 356 (2007) 1736–1741.
[174] C.R. Chang, C.M.Manlandro, D. Arnoult, J. Stadler, A.E. Posey, R.B. Hill, C. Blackstone,
A lethal de novo mutation in the middle domain of the dynamin-related GTPase
Drp1 impairs higher order assembly and mitochondrial division, J. Biol. Chem.
285 (2010) 32494–32503.
[175] H. Ashraﬁan, L. Docherty, V. Leo, C. Towlson, M. Neilan, V. Steeples, C.A. Lygate, T.
Hough, S. Townsend,D.Williams, S.Wells, D. Norris, S. Glyn-Jones, J. Land, I. Barbaric,
Z. Lalanne, P. Denny, D. Szumska, S. Bhattacharya, J.L. Grifﬁn, I. Hargreaves, N.
Fernandez-Fuentes, M. Cheeseman, H. Watkins, T.N. Dear, A mutation in the mito-
chondrial ﬁssion gene Dnm1l leads to cardiomyopathy, PLoS Genet. 6 (2010)
e1001000.
[176] A. Tanaka, S. Kobayashi, Y. Fujiki, Peroxisome division is impaired in a CHO cell
mutant with an inactivating point-mutation in dynamin-like protein 1 gene,
Exp. Cell Res. 312 (2006) 1671–1684.
[177] N. Ishihara, M. Nomura, A. Jofuku, H. Kato, S.O. Suzuki, K. Masuda, H. Otera, Y.
Nakanishi, I. Nonaka, Y. Goto, N. Taguchi, H. Morinaga, M. Maeda, R. Takayanagi,
S. Yokota, K. Mihara, Mitochondrial ﬁssion factor Drp1 is essential for embryonic
development and synapse formation in mice, Nat. Cell Biol. 11 (2009) 958–966.
[178] J. Wakabayashi, Z. Zhang, N. Wakabayashi, Y. Tamura, M. Fukaya, T.W. Kensler,
M. Iijima, H. Sesaki, The dynamin-related GTPase Drp1 is required for embryonic
and brain development in mice, J. Cell Biol. 186 (2009) 805–816.
[179] M. Baes, P. Aubourg, Peroxisomes, myelination, and axonal integrity in the CNS,
Neuroscientist 15 (2009) 367–379.
[180] L. Hulshagen, O. Krysko, A. Bottelbergs, S. Huyghe, R. Klein, P.P. Van Veldhoven, P.P.
De Deyn, R. D'Hooge, D. Hartmann, M. Baes, Absence of functional peroxisomes
from mouse CNS causes dysmyelination and axon degeneration, J. Neurosci. 28
(2008) 4015–4027.
[181] C.M. Kassmann, C. Lappe-Siefke, M. Baes, B. Brugger, A. Mildner, H.B. Werner, O.
Natt, T. Michaelis, M. Prinz, J. Frahm, K.A. Nave, Axonal loss and neuroinﬂamma-
tion caused by peroxisome-deﬁcient oligodendrocytes, Nat. Genet. 39 (2007)
969–976.
[182] N.A. Bonekamp, K. Vormund, R. Jacob, M. Schrader, Dynamin-like protein 1 at
the Golgi complex: a novel component of the sorting/targeting machinery en
route to the plasma membrane, Exp. Cell Res. 316 (2010) 3454–3467.
[183] V. Costa, M. Giacomello, R. Hudec, R. Lopreiato, G. Ermak, D. Lim, W. Malorni, K.J.
Davies, E. Carafoli, L. Scorrano, Mitochondrial ﬁssion and cristae disruption in-
crease the response of cell models of Huntington's disease to apoptotic stimuli,
EMBO Mol. Med. 2 (2010) 490–503.
[184] X. Qi, M.H. Disatnik, N. Shen, R.A. Sobel, D. Mochly-Rosen, Aberrant mitochon-
drial ﬁssion in neurons induced by protein kinase C{delta} under oxidative
stress conditions in vivo, Mol. Biol. Cell 22 (2011) 256–265.
[185] D.I. James, P.A. Parone, Y. Mattenberger, J.C. Martinou, hFis1, a novel component
of the mammalian mitochondrial ﬁssion machinery, J. Biol. Chem. 278 (2003)
36373–36379.
[186] Y.J. Lee, S.Y. Jeong, M. Karbowski, C.L. Smith, R.J. Youle, Roles of the mammalian
mitochondrial ﬁssion and fusion mediators Fis1, Drp1, and Opa1 in apoptosis,
Mol. Biol. Cell 15 (2004) 5001–5011.
[187] D. Stojanovski, O.S. Koutsopoulos, K. Okamoto, M.T. Ryan, Levels of human Fis1
at the mitochondrial outer membrane regulate mitochondrial morphology, J.
Cell Sci. 117 (2004) 1201–1210.
1357M. Schrader et al. / Biochimica et Biophysica Acta 1822 (2012) 1343–1357[188] Y. Yoon, E.W. Krueger, B.J. Oswald, M.A. McNiven, The mitochondrial protein
hFis1 regulates mitochondrial ﬁssion in mammalian cells through an interaction
with the dynamin-like protein DLP1, Mol. Cell. Biol. 23 (2003) 5409–5420.
[189] M.N. Serasinghe, Y. Yoon, The mitochondrial outer membrane protein hFis1
regulates mitochondrial morphology and ﬁssion through self-interaction, Exp.
Cell Res. 314 (2008) 3494–3507.
[190] M.A. Karren, E.M. Coonrod, T.K. Anderson, J.M. Shaw, The role of Fis1p-Mdv1p
interactions in mitochondrial ﬁssion complex assembly, J. Cell Biol. 171 (2005)
291–301.
[191] A.D. Mozdy, J.M. McCaffery, J.M. Shaw, Dnm1p GTPase-mediated mitochondrial
ﬁssion is a multi-step process requiring the novel integral membrane compo-
nent Fis1p, J. Cell Biol. 151 (2000) 367–380.
[192] H.K. Delille, M. Schrader, Targeting of hFis1 to peroxisomes is mediated by
Pex19p, J. Biol. Chem. 283 (2008) 31107–31115.
[193] S. Wasiak, R. Zunino, H.M. McBride, Bax/Bak promote sumoylation of DRP1 and
its stable association with mitochondria during apoptotic cell death, J. Cell Biol.
177 (2007) 439–450.
[194] H. Otera, K. Mihara, Discovery of the membrane receptor for mitochondrial
ﬁssion GTPase Drp1, Small GTPases 2 (2011) 167–172.
[195] R.C. Wells, R.B. Hill, The cytosolic domain of Fis1 binds and reversibly clusters
lipid vesicles, PLoS One 6 (2011) e21384.
[196] L.C. Gomes, L. Scorrano, High levels of Fis1, a pro-ﬁssion mitochondrial protein,
trigger autophagy, Biochim. Biophys. Acta 1777 (2008) 860–866.
[197] D.F. Suen, K.L. Norris, R.J. Youle, Mitochondrial dynamics and apoptosis, Genes
Dev. 22 (2008) 1577–1590.
[198] C.S. Palmer, L.D. Osellame, D. Laine, O.S. Koutsopoulos, A.E. Frazier, M.T. Ryan,
MiD49 and MiD51, new components of the mitochondrial ﬁssion machinery,
EMBO Rep. 12 (2011) 565–573.[199] J. Zhao, T. Liu, S. Jin, X. Wang, M. Qu, P. Uhlen, N. Tomilin, O. Shupliakov, U.
Lendahl, M. Nister, Human MIEF1 recruits Drp1 to mitochondrial outer mem-
branes and promotes mitochondrial fusion rather than ﬁssion, EMBO J. 30
(2011) 2762–2778.
[200] D. Dikov, A.S. Reichert, How to split up: lessons from mitochondria, EMBO J. 30
(2011) 2751–2753.
[201] K.A. Sacksteder, S.J. Gould, The genetics of peroxisome biogenesis, Annu. Rev.
Genet. 34 (2000) 623–652.
[202] A. Cimini, E. Benedetti, B. D'Angelo, L. Cristiano, S. Falone, S. Di Loreto, F. Amicarelli,
M.P. Ceru, Neuronal response of peroxisomal and peroxisome-related proteins to
chronic and acute Abeta injury, Curr. Alzheimer Res. 6 (2009) 238–251.
[203] V.I. Titorenko, S.R. Terlecky, Peroxisome metabolism and cellular aging, Trafﬁc
12 (2011) 252–259.
[204] S. Nagotu, A.M. Krikken, M. Otzen, J.A. Kiel, M. Veenhuis, I.J. van der Klei, Perox-
isome ﬁssion in Hansenula polymorpha requires Mdv1 and Fis1, two proteins
also involved in mitochondrial ﬁssion, Trafﬁc 9 (2008) 1471–1484.
[205] S. Nagotu, R. Saraya, M. Otzen, M. Veenhuis, I.J. van der Klei, Peroxisome prolif-
eration in Hansenula polymorpha requires Dnm1p which mediates ﬁssion but
not de novo formation, Biochim. Biophys. Acta 1783 (2008) 760–769.
[206] J.J. Smith, M. Marelli, R.H. Christmas, F.J. Vizeacoumar, D.J. Dilworth, T. Ideker, T.
Galitski, K. Dimitrov, R.A. Rachubinski, J.D. Aitchison, Transcriptome proﬁling to
identify genes involved in peroxisome assembly and function, J. Cell Biol. 158
(2002) 259–271.
[207] J.A. Kiel, I.J. van der Klei, Proteins involved in microbody biogenesis and deg-
radation in Aspergillus nidulans, Fungal Genet. Biol. 46 (Suppl. 1) (2009)
S62–S71.
[208] X. Zhang, J. Hu, The Arabidopsis chloroplast division protein DYNAMIN-RELATED
PROTEIN5B also mediates peroxisome division, Plant Cell 22 (2010) 431–442.
